1 |
Loessner_2012 |
Employing Live Microbes for Vaccine Delivery |
Loessner, Holger; Schwantes, Astrid; Hamdorf, Matthias; Komor, Uliana; Leschner, Sara; Weiss, Siegfried |
2012 |
2012-02-18 |
PMC |
N |
PMC7123214 |
|
10.1007/978-3-7091-0709-6_5 |
9a4jw0ze |
0.986233 |
Mooney_2013, Tripp_2014, Montefiori_2007 |
Detmer_2006, Tarahomjoo_2011, Pati_2018 |
2 |
Li_W_2014 |
Peptide Vaccine: Progress and Challenges |
Li, Weidang; Joshi, Medha D.; Singhania, Smita; Ramsey, Kyle H.; Murthy, Ashlesh K. |
2014 |
2014-07-02 |
COMM-USE |
N |
PMC4494216 |
26344743.0 |
10.3390/vaccines2030515 |
90p6wiz9 |
0.978977 |
Montefiori_2007, Welsh_2007, Mooney_2013, Lee_S_2015 |
Pati_2018, Tarahomjoo_2011, Bande_2015 |
3 |
Fujita_2017 |
Chapter Eight Nanoparticle-Based Peptide Vaccines |
Fujita, Y.; Taguchi, H. |
2017 |
2017-12-31 |
PMC |
N |
PMC7152328 |
|
10.1016/b978-0-323-39981-4.00008-7 |
npwqz958 |
0.964839 |
Montefiori_2007, Welsh_2007, Li_L_2015 |
Salvador_2011, Cordeiro_2015 |
4 |
Lee_S_2015 |
Recent Advances of Vaccine Adjuvants for Infectious Diseases |
Lee, Sujin; Nguyen, Minh Trang |
2015 |
2015-04-23 |
NONCOMM |
N |
PMC4411509 |
25922593.0 |
10.4110/in.2015.15.2.51 |
dmb0293x |
0.953630 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Pati_2018, Criscuolo_2019, Jiang_2014, Detmer_2006 |
5 |
Babiuk_1994 |
Veterinary vaccines |
Babiuk, L.A.; Potter, A.A. |
1994 |
1994-12-31 |
PMC |
N |
|
|
10.1016/0734-9750(94)90021-3 |
hpm1x0bi |
0.948538 |
Montefiori_2007 |
|
6 |
Salvador_2011 |
An Overview on the Field of Micro- and Nanotechnologies for Synthetic Peptide-Based Vaccines |
Salvador, Aiala; Igartua, Manoli; Hernández, Rosa Maria; Pedraz, José Luis |
2011 |
2011-06-15 |
COMM-USE |
N |
PMC3134826 |
21773041.0 |
10.1155/2011/181646 |
ks7s0uhf |
0.938274 |
Montefiori_2007, Tripp_2014, Mooney_2013 |
Cordeiro_2015, Marques_Neto_2017 |
7 |
Zhao_2017 |
The application of self-assembled nanostructures in peptide-based subunit vaccine development |
Zhao, Guangzu; Chandrudu, Saranya; Skwarczynski, Mariusz; Toth, Istvan |
2017 |
2017-08-31 |
PMC |
N |
PMC7094324 |
|
10.1016/j.eurpolymj.2017.02.014 |
r077ybzg |
0.936606 |
Montefiori_2007, Lee_S_2015 |
Cordeiro_2015, Salvador_2011 |
8 |
Karch_2016 |
Vaccine technologies: From whole organisms to rationally designed protein assemblies |
Karch, Christopher P.; Burkhard, Peter |
2016 |
2016-11-15 |
None |
N |
PMC5079805 |
27157411.0 |
10.1016/j.bcp.2016.05.001 |
ilfh0ds7 |
0.935054 |
Mooney_2013, Montefiori_2007, Tripp_2014 |
Pati_2018, Tarahomjoo_2011, Liu_Z_2014 |
9 |
Perrie_2013 |
Vaccines |
Perrie, Yvonne; Kaur, Randip; Henriksen-Lacey, Malou |
2013 |
2013-10-17 |
PMC |
N |
PMC7120629 |
|
10.1007/978-1-4614-9164-4_17 |
zkawdcac |
0.932703 |
Montefiori_2007, Welsh_2007, Lee_S_2015 |
Criscuolo_2019, Pati_2018, Hajissa_2019, Cordeiro_2015 |
10 |
Raeven_2018 |
Systems vaccinology and big data in the vaccine development chain |
Raeven, René H. M.; van Riet, Elly; Meiring, Hugo D.; Metz, Bernard; Kersten, Gideon F. A. |
2018 |
2018-11-13 |
NONCOMM |
N |
PMC6283655 |
30317555.0 |
10.1111/imm.13012 |
3ywtkd3k |
0.925396 |
|
Wack_2005, Hajissa_2019, Poland_2018, Sesterhenn_2018 |
11 |
Şenel_2011 |
Fundamentals of Vaccine Delivery in Infectious Diseases |
Şenel, Sevda |
2011 |
2011-07-06 |
PMC |
N |
PMC7119968 |
|
10.1007/978-1-4614-0881-9_16 |
cdv6qlwx |
0.913801 |
Mooney_2013, Tripp_2014 |
Pati_2018 |
12 |
Kumar_2019 |
Live-Attenuated Bacterial Vectors for Delivery of Mucosal Vaccines, DNA Vaccines, and Cancer Immunotherapy |
Kumar, Sudeep |
2019 |
2019-01-10 |
PMC |
N |
PMC7123696 |
|
10.1007/978-3-030-01881-8_2 |
1h84yi2i |
0.887392 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Tarahomjoo_2011, Pati_2018, Detmer_2006, Borovjagin_2014 |
13 |
Pati_2018 |
Nanoparticle Vaccines Against Infectious Diseases |
Pati, Rashmirekha; Shevtsov, Maxim; Sonawane, Avinash |
2018 |
2018-10-04 |
COMM-USE |
N |
PMC6180194 |
30337923.0 |
10.3389/fimmu.2018.02224 |
g72rpssy |
0.880572 |
Montefiori_2007, Mooney_2013, Tripp_2014, Lee_S_2015 |
Tarahomjoo_2011, Detmer_2006, Marques_Neto_2017 |
14 |
Lee_N_2012 |
A review of vaccine development and research for industry animals in Korea |
Lee, Nak-Hyung; Lee, Jung-Ah; Park, Seung-Yong; Song, Chang-Seon; Choi, In-Soo; Lee, Joong-Bok |
2012 |
2012-07-31 |
NONCOMM |
N |
PMC3623508 |
23596575.0 |
10.7774/cevr.2012.1.1.18 |
1c1jd9oz |
0.879041 |
Mooney_2013, Tripp_2014 |
Ploquin_2013, Tarahomjoo_2011, Bande_2015 |
15 |
Brun_2008 |
Antigen delivery systems for veterinary vaccine development Viral-vector based delivery systems |
Brun, Alejandro; Albina, Emmanuel; Barret, Tom; Chapman, David A.G.; Czub, Markus; Dixon, Linda K.; Keil, Günther M.; Klonjkowski, Bernard; Le Potier, Marie-Frédérique; Libeau, Geneviève; Ortego, Javier; Richardson, Jennifer; Takamatsu, Haru-H. |
2008 |
2008-12-02 |
PMC |
N |
PMC7131726 |
18838097.0 |
10.1016/j.vaccine.2008.09.044 |
vc9ytkio |
0.876503 |
Montefiori_2007 |
Tarahomjoo_2011, Drexler_2004, Hajissa_2019, Dhama_2008 |
16 |
Moingeon_2002 |
Delivery technologies for human vaccines |
Moingeon, Philippe; de Taisne, Charles; Almond, Jeffrey |
2002 |
2002-07-23 |
PMC |
N |
PMC7110014 |
12176848.0 |
10.1093/bmb/62.1.29 |
v5wxkdbk |
0.874694 |
Montefiori_2007, Welsh_2007 |
Criscuolo_2019, Tarahomjoo_2011, Pati_2018 |
17 |
Jazayeri_2019 |
Recent advances in delivery of veterinary DNA vaccines against avian pathogens |
Jazayeri, Seyed Davoud; Poh, Chit Laa |
2019 |
2019-10-10 |
COMM-USE |
N |
PMC6785882 |
31601266.0 |
10.1186/s13567-019-0698-z |
fmda6klr |
0.864783 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Bande_2015, Ferreira_2005, Dhama_2008, Detmer_2006 |
18 |
Renukaradhya_2015 |
Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation |
Renukaradhya, Gourapura J.; Narasimhan, Balaji; Mallapragada, Surya K. |
2015 |
2015-12-10 |
None |
N |
PMC4760633 |
26410807.0 |
10.1016/j.jconrel.2015.09.047 |
w813iar2 |
0.861088 |
Montefiori_2007, Mooney_2013 |
Pati_2018, Marques_Neto_2017, Criscuolo_2019 |
19 |
Greenberg_2016 |
Vaccination against Viruses |
Greenberg, Harry B.; Dormitzer, Philip R. |
2016 |
2016-12-31 |
PMC |
N |
PMC7152391 |
|
10.1016/b978-0-12-374279-7.14016-0 |
dqikrmk7 |
0.855612 |
Montefiori_2007, Mooney_2013 |
Pati_2018, Falzarano_2011, Hajissa_2019, Elliott_2017 |
20 |
Green_2017 |
Chapter 27 Preclinical Toxicology of Vaccines 1 1 Disclaimer: The findings and conclusions in this chapter have not been formally disseminated by the Food and Drug Administration and should not be construed to represent any Agency determination or policy. |
Green, M.D.; Al-Humadi, N.H. |
2017 |
2017-12-31 |
PMC |
N |
PMC7161388 |
|
10.1016/b978-0-12-803620-4.00027-x |
ea91fnmz |
0.849684 |
Montefiori_2007, Welsh_2007, Lee_S_2015 |
Green_2013, Falzarano_2011, Roberts_2010 |
21 |
Sarkar_2019 |
Selection of adjuvants for vaccines targeting specific pathogens |
Sarkar, Indranil; Garg, Ravendra; van Drunen Littel-van den Hurk, Sylvia |
2019 |
2019-04-22 |
PMC |
N |
PMC7103699 |
31009255.0 |
10.1080/14760584.2019.1604231 |
ywb26cq6 |
0.845642 |
Montefiori_2007 |
Criscuolo_2019 |
22 |
García-Sastre_2013 |
Novel vaccine strategies against emerging viruses |
García-Sastre, Adolfo; Mena, Ignacio |
2013 |
2013-04-30 |
None |
N |
PMC3644304 |
23477832.0 |
10.1016/j.coviro.2013.02.001 |
2hsmt0df |
0.839428 |
Montefiori_2007, Mooney_2013 |
Pati_2018, Elliott_2017, Hajissa_2019 |
23 |
Bull_2015 |
Evolutionary reversion of live viral vaccines: Can genetic engineering subdue it? |
Bull, J. J. |
2015 |
2015-07-31 |
COMM-USE |
N |
PMC4811365 |
27034780.0 |
10.1093/ve/vev005 |
3xb3ibsq |
0.837594 |
|
Bande_2015, Nuismer_2019, Mühlebach_2016, Falzarano_2011 |
24 |
Boudet_2010 |
Vaccines for the Elderly: The Quest for the Ideal Animal Model |
Boudet, F. |
2010 |
2010-01-31 |
PMC |
N |
PMC7094446 |
19897204.0 |
10.1016/j.jcpa.2009.10.005 |
dkqxfqk6 |
0.834135 |
|
Falzarano_2011, Jiang_2014, Hajissa_2019, Poland_2018 |
25 |
Chappuis_1995 |
Control of canine distemper |
Chappuis, G. |
1995 |
1995-05-31 |
PMC |
N |
|
8588329.0 |
10.1016/0378-1135(95)00028-9 |
scwy859p |
0.829860 |
Mooney_2013, Tripp_2014, Morrison_2010 |
|
26 |
Charlton_Hume_2017 |
Platform technologies for modern vaccine manufacturing |
Charlton Hume, Hayley K.; Lua, Linda H.L. |
2017 |
2017-08-16 |
PMC |
N |
PMC7115529 |
28347504.0 |
10.1016/j.vaccine.2017.02.069 |
47sgz7l3 |
0.820646 |
|
Brun_2008 |
27 |
Ferreira_2005 |
Use of adenoviral vectors as veterinary vaccines |
Ferreira, T B; Alves, P M; Aunins, J G; Carrondo, M J T |
2005 |
2005-10-18 |
PMC |
N |
PMC7091679 |
16231058.0 |
10.1038/sj.gt.3302618 |
n3fs7533 |
0.819206 |
Mooney_2013, Montefiori_2007, Tripp_2014 |
Ploquin_2013, Wium_2019, Meseda_2016 |
28 |
Green_2013 |
Chapter 25 Preclinical Toxicology of Vaccines 1 |
Green, Martin David; Hussain Al-Humadi, Nabil |
2013 |
2013-12-31 |
PMC |
N |
PMC7161391 |
|
10.1016/b978-0-12-387815-1.00025-3 |
wwiopinv |
0.814766 |
Montefiori_2007, Welsh_2007, Lee_S_2015 |
Green_2017, Roberts_2010, Pati_2018 |
29 |
Plotkin_2005 |
Vaccines: past, present and future |
Plotkin, Stanley A |
2005 |
2005-04-05 |
PMC |
N |
PMC7095920 |
15812490.0 |
10.1038/nm1209 |
k5u9nt8b |
0.808178 |
Montefiori_2007, Tripp_2014 |
Pati_2018, Mühlebach_2016, Dhama_2008, Tarahomjoo_2011 |
30 |
O’Connell_2020 |
Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises |
O’Connell, Aoife K.; Douam, Florian |
2020 |
2020-01-21 |
COMM-USE |
N |
PMC7157703 |
31973073.0 |
10.3390/vaccines8010036 |
7br852ma |
0.805784 |
Montefiori_2007 |
|
31 |
Bose_2019 |
Biodegradable polymers for modern vaccine development |
Bose, Rajendran JC; Kim, Minwoo; Chang, Ji Hyun; Paulmurugan, Ramasamy; Moon, James J.; Koh, Won-Gun; Lee, Soo-Hong; Park, Hansoo |
2019 |
2019-09-25 |
PMC |
N |
PMC7129903 |
|
10.1016/j.jiec.2019.04.044 |
s2v0tpsg |
0.805546 |
Montefiori_2007, Mooney_2013, Lee_S_2015 |
Cordeiro_2015, Salvador_2011 |
32 |
Pearson_1986 |
Vaccines and Principles of Immunization |
Pearson, Renée C.; Dhein, Cheryl R.; Gorham, John R. |
1986 |
1986-11-30 |
PMC |
N |
PMC7134508 |
3538634.0 |
10.1016/s0195-5616(86)50138-8 |
1v5xisvl |
0.802899 |
Mooney_2013, Montefiori_2007 |
Criscuolo_2019, Rajan_2014 |
33 |
Francis_2018 |
Recent Advances in Vaccine Technologies |
Francis, Michael James |
2018 |
2018-03-31 |
PMC |
N |
PMC7132473 |
29217317.0 |
10.1016/j.cvsm.2017.10.002 |
4xkux5z4 |
0.793774 |
Mooney_2013 |
Testa_2012, Hajissa_2019, Brun_2008, Criscuolo_2019 |
34 |
Ingolotti_2010 |
DNA vaccines for targeting bacterial infections |
Ingolotti, Mariana; Kawalekar, Omkar; Shedlock, Devon J; Muthumani, Karuppiah; Weiner, David B |
2010 |
2010-07-01 |
PMC |
N |
PMC2962930 |
20624048.0 |
10.1586/erv.10.57 |
hivpamvs |
0.788399 |
Montefiori_2007 |
Detmer_2006, Liu_L_2017, Dhama_2008 |
35 |
Balke_2020 |
Recent Advances in the Use of Plant Virus-Like Particles as Vaccines |
Balke, Ina; Zeltins, Andris |
2020 |
2020-02-28 |
COMM-USE |
N |
PMC7150928 |
32121192.0 |
10.3390/v12030270 |
th7jtbhm |
0.784693 |
Mooney_2013, Montefiori_2007 |
|
36 |
Bolhassani_2011 |
Improvement of different vaccine delivery systems for cancer therapy |
Bolhassani, Azam; Safaiyan, Shima; Rafati, Sima |
2011 |
2011-01-07 |
COMM-USE |
N |
PMC3024302 |
21211062.0 |
10.1186/1476-4598-10-3 |
ya410nbj |
0.779353 |
Montefiori_2007 |
Liu_L_2017, Pati_2018 |
37 |
Atmaca_2015 |
Vaccines and Vaccination |
Atmaca, Hasan Tarik |
2015 |
2015-04-08 |
PMC |
N |
PMC7122016 |
|
10.1007/978-3-662-46789-3_3 |
vysn9vnz |
0.777995 |
Mooney_2013 |
Rajan_2014 |
38 |
Criscuolo_2019 |
Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines |
Criscuolo, E.; Caputo, V.; Diotti, R. A.; Sautto, G. A.; Kirchenbaum, G. A.; Clementi, N. |
2019 |
2019-03-04 |
COMM-USE |
N |
PMC6425294 |
30949518.0 |
10.1155/2019/8303648 |
0xo2fiop |
0.775775 |
Montefiori_2007, Mooney_2013, Lee_S_2015, Tripp_2014 |
Meseda_2016, Wilson_2020 |
39 |
Wack_2005 |
Vaccinology at the beginning of the 21st century |
Wack, Andreas; Rappuoli, Rino |
2005 |
2005-08-31 |
PMC |
N |
PMC7125631 |
15950445.0 |
10.1016/j.coi.2005.05.005 |
qfdxri93 |
0.775354 |
Montefiori_2007 |
Hajissa_2019, Pati_2018, Lauer_2016 |
40 |
López-Sagaseta_2015 |
Self-assembling protein nanoparticles in the design of vaccines |
López-Sagaseta, Jacinto; Malito, Enrico; Rappuoli, Rino; Bottomley, Matthew J. |
2015 |
2015-11-26 |
None |
N |
PMC4706605 |
26862374.0 |
10.1016/j.csbj.2015.11.001 |
fxr8ywxx |
0.769650 |
Mooney_2013, Montefiori_2007, Tripp_2014 |
Cordeiro_2015, Pati_2018 |
41 |
Kanekiyo_2017 |
Chapter 4 Virus-Like Particle and Nanoparticle Vaccines |
Kanekiyo, M.; Buck, C.B. |
2017 |
2017-12-31 |
PMC |
N |
PMC7150090 |
|
10.1016/b978-0-12-802302-0.00003-0 |
zlr7lkqx |
0.768231 |
Montefiori_2007 |
Cordeiro_2015, Liu_Z_2014, Salvador_2011 |
42 |
Ayalew_2015 |
Bovine adenovirus-3 as a vaccine delivery vehicle |
Ayalew, Lisanework E.; Kumar, Pankaj; Gaba, Amit; Makadiya, Niraj; Tikoo, Suresh K. |
2015 |
2015-01-15 |
PMC |
N |
PMC7115382 |
25498212.0 |
10.1016/j.vaccine.2014.11.055 |
k3cme2s2 |
0.760296 |
Mooney_2013, Tripp_2014, Montefiori_2007, Kopecky-Bromberg_2009 |
Hammond_2005, Ferreira_2005, Tarahomjoo_2011 |
43 |
Liu_Z_2014 |
A novel method for synthetic vaccine construction based on protein assembly |
Liu, Zhida; Zhou, Hang; Wang, Wenjun; Tan, Wenjie; Fu, Yang-Xin; Zhu, Mingzhao |
2014 |
2014-12-01 |
NONCOMM |
N |
PMC4248271 |
25434527.0 |
10.1038/srep07266 |
2tazu4y6 |
0.753420 |
Tripp_2014, Montefiori_2007, Mooney_2013 |
Mühlebach_2016, Karch_2016, Tarahomjoo_2011 |
44 |
Diaz-Arévalo_2020 |
Chapter 7 Nanoparticle-based vaccines opportunities and limitations |
Diaz-Arévalo, Diana; Zeng, Mingtao |
2020 |
2020-12-31 |
PMC |
N |
PMC7153331 |
|
10.1016/b978-0-12-817778-5.00007-5 |
l7dehit8 |
0.752457 |
Montefiori_2007, Mooney_2013, Tripp_2014, Lee_S_2015 |
Pati_2018, Cordeiro_2015 |
45 |
Folgori_2012 |
Engineered Viruses as Vaccine Platforms |
Folgori, Antonella; Capone, Stefania |
2012 |
2012-03-29 |
PMC |
N |
PMC7120934 |
|
10.1007/978-94-007-4543-8_4 |
xvji54bo |
0.752299 |
Montefiori_2007, Mooney_2013 |
Tatsis_2004, Mühlebach_2016, Borovjagin_2014, Tarahomjoo_2011 |
46 |
Sanders_2017 |
Vectored immunoprophylaxis: an emerging adjunct to traditional vaccination |
Sanders, John W.; Ponzio, Todd A. |
2017 |
2017-02-10 |
COMM-USE |
N |
PMC5531025 |
28883973.0 |
10.1186/s40794-017-0046-0 |
66nxk4e8 |
0.745683 |
Montefiori_2007 |
Ploquin_2013 |
47 |
Chalmers_2006 |
Overview of new vaccines and technologies |
Chalmers, W.S.K. |
2006 |
2006-10-05 |
PMC |
N |
PMC7131788 |
16723197.0 |
10.1016/j.vetmic.2006.04.006 |
34nnp9cv |
0.744548 |
Montefiori_2007, Lee_S_2015, Wiersma_2015 |
Criscuolo_2019, Bivas-Benita_2005, Pati_2018 |
48 |
Poland_2018 |
Personalized vaccinology: A review |
Poland, G.A.; Ovsyannikova, I.G.; Kennedy, R.B. |
2018 |
2018-08-28 |
PMC |
N |
PMC5792371 |
28774561.0 |
10.1016/j.vaccine.2017.07.062 |
ipa017wz |
0.742038 |
Montefiori_2007 |
Hajissa_2019, Criscuolo_2019, Jin_J_2018, Jiang_2014 |
49 |
Aurisicchio_2011 |
Emerging Cancer Vaccines: The Promise of Genetic Vectors |
Aurisicchio, Luigi; Ciliberto, Gennaro |
2011 |
2011-09-22 |
COMM-USE |
N |
PMC3759217 |
24212974.0 |
10.3390/cancers3033687 |
l5xw1u8x |
0.741592 |
Montefiori_2007, Mooney_2013, Testa_2012 |
Garu_2016, Borovjagin_2014, Hutzler_2017, Cervantes-Barragan_2010 |
50 |
Pravieux_2007 |
Protection of Newborn Animals through Maternal Immunization |
Pravieux, J.J.; Poulet, H.; Charreyre, C.; Juillard, V. |
2007 |
2007-07-31 |
PMC |
N |
PMC7094439 |
17559866.0 |
10.1016/j.jcpa.2007.04.009 |
3kod0oah |
0.738054 |
Montefiori_2007 |
Rajan_2014 |
51 |
Syomin_2019 |
Virus-Like Particles as an Instrument of Vaccine Production |
Syomin, B. V.; Ilyin, Y. V. |
2019 |
2019-06-17 |
PMC |
N |
PMC7088979 |
|
10.1134/s0026893319030154 |
7mu530yp |
0.728599 |
Montefiori_2007 |
Kushnir_2012, Fuenmayor_2017, Rosales-Mendoza_2019 |
52 |
Liu_L_2017 |
Clinical Use of DNA Vaccines |
Liu, Li; Morrow, Matthew P.; Bagarazzi, Mark |
2017 |
2017-07-25 |
PMC |
N |
PMC7153459 |
|
10.1007/978-3-319-32886-7_106 |
qautse9a |
0.727398 |
Montefiori_2007, Mooney_2013, Li_L_2015 |
Dhama_2008, Ingolotti_2010, Garu_2016, Li_L_2015 |
53 |
Welsh_2007 |
Pathogenic epitopes, heterologous immunity and vaccine design |
Welsh, Raymond M.; Fujinami, Robert S. |
2007 |
2007-01-01 |
PMC |
N |
PMC7097378 |
17558423.0 |
10.1038/nrmicro1709 |
6y0xvp37 |
0.720429 |
Montefiori_2007, Tripp_2014, Wiersma_2015 |
Testa_2012, Jin_J_2018, Hajissa_2019 |
54 |
Detmer_2006 |
Live bacterial vaccines – a review and identification of potential hazards |
Detmer, Ann; Glenting, Jacob |
2006 |
2006-06-23 |
COMM-USE |
N |
PMC1538998 |
16796731.0 |
10.1186/1475-2859-5-23 |
exm1rv1w |
0.714880 |
Montefiori_2007, Tripp_2014, Mooney_2013 |
Tarahomjoo_2011, Wium_2019, Pati_2018 |
55 |
Nieto_2014 |
AAV Vectors Vaccines Against Infectious Diseases |
Nieto, Karen; Salvetti, Anna |
2014 |
2014-01-21 |
COMM-USE |
N |
PMC3896988 |
24478774.0 |
10.3389/fimmu.2014.00005 |
b6jpyr0u |
0.709066 |
Bangari_2006 |
Tatsis_2004, Bangari_2006 |
56 |
Tarahomjoo_2011 |
Development of Vaccine Delivery Vehicles Based on Lactic Acid Bacteria |
Tarahomjoo, Shirin |
2011 |
2011-09-07 |
PMC |
N |
PMC7090618 |
21901278.0 |
10.1007/s12033-011-9450-2 |
b8mfn6o9 |
0.707734 |
Montefiori_2007 |
Detmer_2006, Bermúdez-Humarán_2009, Bermúdez-Humarán_2011 |
57 |
Lee_J_2018 |
Engineering DNA vaccines against infectious diseases |
Lee, Jihui; Arun Kumar, Shreedevi; Jhan, Yong Yu; Bishop, Corey J. |
2018 |
2018-10-15 |
PMC |
N |
PMC7105045 |
30172933.0 |
10.1016/j.actbio.2018.08.033 |
pux58dut |
0.701166 |
|
Pati_2018, Liu_L_2017, Tarahomjoo_2011, Borovjagin_2014 |
58 |
Mühlebach_2017 |
Vaccine platform recombinant measles virus |
Mühlebach, Michael D. |
2017 |
2017-07-14 |
PMC |
N |
PMC7089060 |
28710608.0 |
10.1007/s11262-017-1486-3 |
ttcaxqyy |
0.697029 |
Mooney_2013, Montefiori_2007, Tripp_2014 |
Mühlebach_2016, Akahata_2010, Falzarano_2011 |
59 |
Enjuanes_2016 |
Chapter Eight Molecular Basis of Coronavirus Virulence and Vaccine Development |
Enjuanes, L.; Zuñiga, S.; Castaño-Rodriguez, C.; Gutierrez-Alvarez, J.; Canton, J.; Sola, I. |
2016 |
2016-12-31 |
PMC |
N |
PMC7112271 |
27712626.0 |
10.1016/bs.aivir.2016.08.003 |
kuuyvf90 |
0.696124 |
Montefiori_2007, Mooney_2013 |
Zakhartchouk_2005, Akahata_2010, Mühlebach_2016 |
60 |
Cordeiro_2015 |
Nanoengineering of vaccines using natural polysaccharides |
Cordeiro, Ana Sara; Alonso, María José; de la Fuente, María |
2015 |
2015-11-01 |
PMC |
N |
PMC7127432 |
26049133.0 |
10.1016/j.biotechadv.2015.05.010 |
tozv6u89 |
0.692551 |
Montefiori_2007, Lee_S_2015 |
Marques_Neto_2017, Tarahomjoo_2011, Sarkar_2013 |
61 |
Moss_2009 |
Prospects for control of emerging infectious diseases with plasmid DNA vaccines |
Moss, Ronald B |
2009 |
2009-09-07 |
COMM-USE |
N |
PMC2746192 |
19735569.0 |
10.1186/1476-8518-7-3 |
1a5u7uux |
0.690228 |
Mooney_2013 |
Ingolotti_2010, Lu_S_2009, Dhama_2008, Mühlebach_2016 |
62 |
Sesterhenn_2018 |
Structure-based immunogen design—leading the way to the new age of precision vaccines |
Sesterhenn, Fabian; Bonet, Jaume; Correia, Bruno E |
2018 |
2018-08-31 |
PMC |
N |
PMC7127059 |
29980105.0 |
10.1016/j.sbi.2018.06.002 |
0ks8m213 |
0.686197 |
Montefiori_2007 |
Jin_J_2018, Hajissa_2019, Dormitzer_2008 |
63 |
De_Gregorio_2012 |
Vaccines for the future: learning from human immunology |
De Gregorio, Ennio; Rappuoli, Rino |
2012 |
2012-02-20 |
PMC |
N |
PMC3815775 |
21880117.0 |
10.1111/j.1751-7915.2011.00276.x |
1fgz2fyr |
0.683745 |
Montefiori_2007 |
Pati_2018, Elliott_2017, Bande_2015 |
64 |
Holman_2009 |
Chapter 7 Viral Vectors |
Holman, David H.; Wang, Danher; Woraratanadharm, Jan; Dong, John Y. |
2009 |
2009-12-31 |
PMC |
N |
PMC7149693 |
|
10.1016/b978-0-12-369408-9.00007-x |
82g5eiyg |
0.682989 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Mühlebach_2016, Tarahomjoo_2011, Akahata_2010, de_Vries_2016 |
65 |
Hammond_2009 |
Plant Production of Veterinary Vaccines and Therapeutics |
Hammond, R. W.; Nemchinov, L. G. |
2009 |
2009-01-01 |
PMC |
N |
PMC7122226 |
19401822.0 |
10.1007/978-3-540-70868-1_5 |
xasktk5c |
0.675884 |
|
Korban_2002, Rajan_2014 |
66 |
Plitnick_2013 |
Chapter 9 Global Regulatory Guidelines for Vaccines |
Plitnick, Lisa M. |
2013 |
2013-12-31 |
PMC |
N |
PMC7149671 |
|
10.1016/b978-0-12-394810-6.00009-5 |
3c68yz4j |
0.675884 |
Mooney_2013 |
Moingeon_2002, Criscuolo_2019, Loessner_2012 |
67 |
Black_2010 |
Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists |
Black, Matthew; Trent, Amanda; Tirrell, Matthew; Olive, Colleen |
2010 |
2010-02-01 |
PMC |
N |
PMC2837080 |
20109027.0 |
10.1586/erv.09.160 |
sp4w2tva |
0.674814 |
Montefiori_2007, Lee_S_2015 |
Salvador_2011 |
68 |
De_Gregorio_2014 |
From empiricism to rational design: a personal perspective of the evolution of vaccine development |
De Gregorio, Ennio; Rappuoli, Rino |
2014 |
2014-06-13 |
PMC |
N |
PMC7096907 |
24925139.0 |
10.1038/nri3694 |
9guym4a9 |
0.674510 |
|
Meseda_2016, Poland_2018, Hajissa_2019 |
69 |
Crisci_2013 |
Virus-like particle-based vaccines for animal viral infections |
Crisci, Elisa; Bárcena, Juan; Montoya, María |
2013 |
2013-09-30 |
PMC |
N |
PMC7115488 |
|
10.1016/j.inmuno.2012.08.002 |
jjluocxz |
0.671822 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Crisci_2012, Akahata_2010, Liu_J_2016, Ploquin_2013 |
70 |
Lu_S_2009 |
Chapter 8 DNA Vaccines for Biodefense and Emerging and Neglected Infectious Diseases |
Lu, Shan; Grimes-Serrano, Jill M.; Wang, Shixia |
2009 |
2009-12-31 |
PMC |
N |
PMC7150048 |
|
10.1016/b978-0-12-369408-9.00008-1 |
x3at6mgp |
0.670808 |
Mooney_2013 |
Dhama_2008, Zakhartchouk_2005, Pati_2018 |
71 |
Liu_S_2016 |
DNA immunization as a technology platform for monoclonal antibody induction |
Liu, Shuying; Wang, Shixia; Lu, Shan |
2016 |
2016-04-06 |
COMM-USE |
N |
PMC4855071 |
27048742.0 |
10.1038/emi.2016.27 |
jnsis3gf |
0.669727 |
Montefiori_2007, Welsh_2007 |
Hao_H_2008 |
72 |
Sharma_2019 |
Moving from Empirical to Rational Vaccine Design in the ‘Omics’ Era |
Sharma, Mansi; Krammer, Florian; García-Sastre, Adolfo; Tripathi, Shashank |
2019 |
2019-08-14 |
COMM-USE |
N |
PMC6789792 |
31416125.0 |
10.3390/vaccines7030089 |
3ij0n387 |
0.666240 |
Montefiori_2007 |
Jin_J_2018, Hajissa_2019 |
73 |
Testa_2012 |
Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications |
Testa, James S; Philip, Ramila |
2012 |
2012-11-01 |
PMC |
N |
PMC3636528 |
23630544.0 |
10.2217/fvl.12.108 |
h29lujpi |
0.666240 |
Montefiori_2007, Mooney_2013, Tripp_2014, Wiersma_2015 |
Hajissa_2019, Busch_2020, Pati_2018, Jin_J_2018 |
74 |
Cui_Z_2005 |
DNA Vaccine |
Cui, Zhengrong |
2005 |
2005-12-31 |
PMC |
N |
PMC7119308 |
16096015.0 |
10.1016/s0065-2660(05)54011-2 |
cetmg1km |
0.666206 |
|
Ingolotti_2010, Li_L_2015, Liu_L_2017 |
75 |
Soler_2007 |
Preparation of recombinant vaccines |
Soler, Eric; Houdebine, Louis-Marie |
2007 |
2007-12-31 |
PMC |
N |
PMC7106376 |
17875474.0 |
10.1016/s1387-2656(07)13004-0 |
1tjtdcug |
0.662038 |
Welsh_2007 |
Mühlebach_2016, Tarahomjoo_2011, Lamphear_2002 |
76 |
Donaldson_2018 |
Virus-like particle vaccines: immunology and formulation for clinical translation |
Donaldson, Braeden; Lateef, Zabeen; Walker, Greg F.; Young, Sarah L.; Ward, Vernon K. |
2018 |
2018-09-19 |
PMC |
N |
PMC7103734 |
30173619.0 |
10.1080/14760584.2018.1516552 |
n2ncamqh |
0.657633 |
Mooney_2013, Montefiori_2007, Tripp_2014 |
Meseda_2016, Criscuolo_2019, Akahata_2010 |
77 |
McFarland_2011 |
Non-animal replacement methods for human vaccine potency testing: state of the science and future directions |
McFarland, Richard; Verthelyi, Daniela; Casey, Warren; Arciniega, Juan; Isbrucker, Richard; Schmitt, Michael; Finn, Theresa; Descamps, Johan; Horiuchi, Yoshinobu; Sesardic, Dorothea; Stickings, Paul; Johnson, Nelson W; Lipscomb, Elizabeth; Allen, David |
2011 |
2011-12-31 |
PMC |
N |
|
|
10.1016/j.provac.2011.10.002 |
dxbvfwqu |
0.656720 |
Mooney_2013, Tripp_2014, Montefiori_2007 |
Falzarano_2011, Bande_2015, Keshwara_2019 |
78 |
Shrestha_2019 |
Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines |
Shrestha, Ashish C.; Wijesundara, Danushka K.; Masavuli, Makutiro G.; Mekonnen, Zelalem A.; Gowans, Eric J.; Grubor-Bauk, Branka |
2019 |
2019-04-30 |
COMM-USE |
N |
PMC6630607 |
31052178.0 |
10.3390/vaccines7020038 |
141u6ax7 |
0.656282 |
Montefiori_2007, Li_L_2015 |
Liu_L_2017, Cordeiro_2015 |
79 |
Saade_2012 |
Technologies for enhanced efficacy of DNA vaccines |
Saade, Fadi; Petrovsky, Nikolai |
2012 |
2012-02-01 |
PMC |
N |
PMC3293989 |
22309668.0 |
10.1586/erv.11.188 |
nh1eqwmo |
0.651884 |
Montefiori_2007 |
Li_L_2015, Liu_L_2017, Ingolotti_2010, Li_L_2012 |
80 |
Schindewolf_2019 |
Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism |
Schindewolf, Craig; Menachery, Vineet D. |
2019 |
2019-01-17 |
COMM-USE |
N |
PMC6356267 |
30658390.0 |
10.3390/v11010074 |
cy45w8vq |
0.651598 |
Mooney_2013 |
Du_L_2015 |
81 |
Li_L_2012 |
The future of human DNA vaccines |
Li, Lei; Saade, Fadi; Petrovsky, Nikolai |
2012 |
2012-12-01 |
PMC |
N |
PMC3511659 |
22981627.0 |
10.1016/j.jbiotec.2012.08.012 |
qpgq6dgn |
0.650235 |
Mooney_2013, Li_L_2015 |
Li_L_2015, Ingolotti_2010, Liu_L_2017, Saade_2012 |
82 |
Liu_M_2019 |
A Comparison of Plasmid DNA and mRNA as Vaccine Technologies |
Liu, Margaret A. |
2019 |
2019-04-24 |
COMM-USE |
N |
PMC6631684 |
31022829.0 |
10.3390/vaccines7020037 |
0fx1b7ph |
0.649682 |
Montefiori_2007, Li_L_2015 |
Ingolotti_2010, Li_L_2015, Liu_L_2017, Dhama_2008 |
83 |
Matsuo_2013 |
Frontiers of transcutaneous vaccination systems: Novel technologies and devices for vaccine delivery |
Matsuo, Kazuhiko; Hirobe, Sachiko; Okada, Naoki; Nakagawa, Shinsaku |
2013 |
2013-05-01 |
PMC |
N |
PMC7125630 |
23523401.0 |
10.1016/j.vaccine.2013.03.022 |
gcuz6edd |
0.647546 |
|
Ishii_2008, Hansen_2012, Criscuolo_2019 |
84 |
Barclay_2017 |
Chapter Seven Vaccine Adjuvant Nanotechnologies |
Barclay, T.; Petrovsky, N. |
2017 |
2017-12-31 |
PMC |
N |
PMC7151801 |
|
10.1016/b978-0-323-39981-4.00007-5 |
7t1bzc7f |
0.646439 |
Montefiori_2007, Lee_S_2015 |
Cordeiro_2015, Marques_Neto_2017 |
85 |
Enjuanes_2008 |
Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease |
Enjuanes, Luis; DeDiego, Marta L.; Álvarez, Enrique; Deming, Damon; Sheahan, Tim; Baric, Ralph |
2008 |
2008-04-30 |
None |
N |
PMC2633062 |
17416434.0 |
10.1016/j.virusres.2007.01.021 |
gysf0vbv |
0.643347 |
Mooney_2013, Tripp_2014 |
Escriou_2014, Gai_W_2011, Akahata_2010, Haagmans_2009 |
86 |
Dumonteil_2007 |
DNA Vaccines against Protozoan Parasites: Advances and Challenges |
Dumonteil, Eric |
2007 |
2007-06-24 |
PMC |
N |
PMC1940056 |
17710244.0 |
10.1155/2007/90520 |
1n69h3i3 |
0.640308 |
Montefiori_2007 |
Hajissa_2019, Wium_2019, Ploquin_2013 |
87 |
Al-Halifa_2019 |
Nanoparticle-Based Vaccines Against Respiratory Viruses |
Al-Halifa, Soultan; Gauthier, Laurie; Arpin, Dominic; Bourgault, Steve; Archambault, Denis |
2019 |
2019-01-24 |
COMM-USE |
N |
PMC6353795 |
30733717.0 |
10.3389/fimmu.2019.00022 |
uxtkks8d |
0.640143 |
Mooney_2013, Tripp_2014, Montefiori_2007 |
Lee_Y_2018, Broadbent_2015, Lee_T_2017 |
88 |
Hobernik_2018 |
DNA Vaccines—How Far From Clinical Use? |
Hobernik, Dominika; Bros, Matthias |
2018 |
2018-11-15 |
COMM-USE |
N |
PMC6274812 |
30445702.0 |
10.3390/ijms19113605 |
zhjp3bd2 |
0.639560 |
Montefiori_2007 |
Garu_2016, Liu_L_2017, Kim_S_2012 |
89 |
De_Groot_2008 |
Epitope-Based Immunome-Derived Vaccines: A Strategy for Improved Design and Safety |
De Groot, Anne S.; Moise, Leonard; McMurry, Julie A.; Martin, William |
2008 |
2008-07-31 |
PMC |
N |
PMC7122239 |
|
10.1007/978-0-387-79208-8_3 |
fuv157f1 |
0.639461 |
Montefiori_2007 |
Jin_J_2018 |
90 |
Borovjagin_2014 |
Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccines |
Borovjagin, Anton V.; Gomez-Gutierrez, Jorge G.; Shirwan, Haval; Matthews, Qiana L. |
2014 |
2014-07-16 |
PMC |
N |
PMC7121347 |
|
10.1007/978-3-7091-1818-4_8 |
7eqpb7ge |
0.635806 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Mühlebach_2016, Pati_2018, Tarahomjoo_2011 |
91 |
Kutzler_2008 |
DNA vaccines: ready for prime time? |
Kutzler, Michele A.; Weiner, David B. |
2008 |
2008-10-01 |
PMC |
N |
PMC4317294 |
18781156.0 |
10.1038/nrg2432 |
rb1r88oq |
0.633062 |
|
Li_L_2015, Ingolotti_2010, Liu_L_2017 |
92 |
Szatraj_2017 |
Lactic acid bacteria — promising vaccine vectors: possibilities, limitations, doubts |
Szatraj, K.; Szczepankowska, A.K.; Chmielewska‐Jeznach, M. |
2017 |
2017-04-04 |
PMC |
N |
PMC7166332 |
28295939.0 |
10.1111/jam.13446 |
33nmtbew |
0.631444 |
Montefiori_2007, Tripp_2014, Mooney_2013 |
|
93 |
Bermúdez-Humarán_2009 |
Development of Mucosal Vaccines Based on Lactic Acid Bacteria |
Bermúdez-Humarán, Luis G.; Innocentin, Silvia; Lefèvre, Francois; Chatel, Jean-Marc; Langella, Philippe |
2009 |
2009-01-01 |
PMC |
N |
PMC7121035 |
|
10.1007/978-0-387-79058-9_29 |
tfwllrfz |
0.631377 |
Montefiori_2007 |
Tarahomjoo_2011, Bermúdez-Humarán_2011, Wells_2008, Detmer_2006 |
94 |
Taylor_2014 |
Vaccines Against Viral Infections |
Taylor, Milton W. |
2014 |
2014-07-22 |
PMC |
N |
PMC7123619 |
|
10.1007/978-3-319-07758-1_19 |
c8vwlbnh |
0.629807 |
Mooney_2013 |
Olszewska_2006, Akahata_2010, Zakhartchouk_2005 |
95 |
Fioretti_2010 |
DNA Vaccines: Developing New Strategies against Cancer |
Fioretti, Daniela; Iurescia, Sandra; Fazio, Vito Michele; Rinaldi, Monica |
2010 |
2010-03-28 |
PMC |
N |
PMC2846346 |
20368780.0 |
10.1155/2010/174378 |
epkw6222 |
0.627365 |
Montefiori_2007, Welsh_2007, Li_L_2015 |
Liu_L_2017, Pati_2018, Ingolotti_2010, Dhama_2008 |
96 |
Tatsis_2004 |
Adenoviruses as vaccine vectors |
Tatsis, Nia; Ertl, Hildegund C.J. |
2004 |
2004-10-31 |
PMC |
N |
PMC7106330 |
15451446.0 |
10.1016/j.ymthe.2004.07.013 |
aw8p35c5 |
0.624887 |
Montefiori_2007, Bangari_2006 |
Bangari_2006, Singh_2016, Borovjagin_2014, Mittal_2016 |
97 |
DeLong_2016 |
Towards RNA Nanoparticle Vaccines: Synergizing RNA and Inorganic Nanoparticles to Achieve Immuno-potentiation |
DeLong, Robert K.; Curtis, Chandler B. |
2016 |
2016-06-16 |
PMC |
N |
PMC5443121 |
27312869.0 |
10.1002/wnan.1415 |
0bvft710 |
0.620138 |
Montefiori_2007 |
Cordeiro_2015, Ingolotti_2010 |
98 |
Lauer_2016 |
Multivalent and Multipathogen Viral Vector Vaccines |
Lauer, Katharina B.; Borrow, Ray; Blanchard, Thomas J. |
2016 |
2016-08-17 |
None |
N |
PMC5216423 |
27535837.0 |
10.1128/cvi.00298-16 |
i1jrh446 |
0.617129 |
Montefiori_2007, Mooney_2013, Tripp_2014, de_Vries_2016 |
Ploquin_2013, Meseda_2016, Zakhartchouk_2005 |
99 |
Chase_2008 |
Neonatal Immune Development in the Calf and Its Impact on Vaccine Response |
Chase, Christopher C.L.; Hurley, David J.; Reber, Adrian J. |
2008 |
2008-03-31 |
PMC |
N |
PMC7127081 |
18299033.0 |
10.1016/j.cvfa.2007.11.001 |
g6w27q0g |
0.612741 |
Montefiori_2007 |
Nazmi_2017 |
100 |
Giacalone_2006 |
Immune responses elicited by bacterial minicells capable of simultaneous DNA and protein antigen delivery |
Giacalone, Matthew J.; Sabbadini, Roger A.; Chambers, Amy L.; Pillai, Sabitha; McGuire, Kathleen L. |
2006 |
2006-08-14 |
PMC |
N |
PMC7125846 |
16806602.0 |
10.1016/j.vaccine.2006.04.063 |
52l63ss3 |
0.610487 |
Montefiori_2007 |
Tarahomjoo_2011, Ingolotti_2010 |
101 |
Kurup_2019 |
Edible Vaccines: Promises and Challenges |
Kurup, Vrinda M; Thomas, Jaya |
2019 |
2019-11-22 |
PMC |
N |
PMC7090473 |
31758488.0 |
10.1007/s12033-019-00222-1 |
b264k3gy |
0.610139 |
Montefiori_2007, Tripp_2014, Welsh_2007, Mooney_2013 |
Pati_2018, Criscuolo_2019 |
102 |
Gamble_2010 |
Current progress in the development of a prophylactic vaccine for HIV-1 |
Gamble, Lena J; Matthews, Qiana L |
2010 |
2010-12-22 |
PMC |
N |
PMC3023272 |
21267356.0 |
10.2147/dddt.s6959 |
ep7ezoko |
0.609493 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Vaine_2009, Akahata_2010 |
103 |
Jeong_2017 |
Exploiting virus-like particles as innovative vaccines against emerging viral infections |
Jeong, Hotcherl; Seong, Baik Lin |
2017 |
2017-02-28 |
PMC |
N |
PMC7090582 |
28243941.0 |
10.1007/s12275-017-7058-3 |
4h02bb70 |
0.607457 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Tarahomjoo_2011, Chen_2016, Pati_2018 |
104 |
Morrison_2010 |
Newcastle disease virus-like particles as a platform for the development of vaccines for human and agricultural pathogens |
Morrison, Trudy G |
2010 |
2010-09-01 |
PMC |
N |
PMC3039435 |
21339837.0 |
10.2217/fvl.10.50 |
4fehbpjr |
0.605252 |
Mooney_2013, Tripp_2014 |
Ploquin_2013, Choi_2017, Falzarano_2011, Mühlebach_2016 |
105 |
Hedegaard_2016 |
Passive immunisation, an old idea revisited: Basic principles and application to modern animal production systems |
Hedegaard, Chris J.; Heegaard, Peter M.H. |
2016 |
2016-06-30 |
PMC |
N |
PMC7127230 |
27185263.0 |
10.1016/j.vetimm.2016.04.007 |
cu7sn3iy |
0.603773 |
Montefiori_2007, Tripp_2014, Welsh_2007 |
Gerber_1990 |
106 |
D’Souza_2015 |
Chapter 5 Trends in Nonparenteral Delivery of Biologics, Vaccines and Cancer Therapies |
D’Souza, Martin J.; Gala, Rikhav P.; Ubale, Ruhi V.; D’Souza, Bernadette; Vo, Trinh Phuong; Parenky, Ashwin C.; Mulla, Nihal S.; D’Sa, Sucheta; D’Souza, Marissa; Braz-Gomes, Kim; D’Souza, Nigel; Chiriva-Internati, Maurizio; Zughaier, Susu |
2015 |
2015-12-31 |
PMC |
N |
PMC7150203 |
|
10.1016/b978-0-12-416603-5.00005-5 |
cldrzet3 |
0.603604 |
Montefiori_2007, Mooney_2013, Tripp_2014, Lee_S_2015 |
Kraan_2014, Cordeiro_2015, Criscuolo_2019 |
107 |
Ramvikas_2017 |
Chapter Fifteen Nasal Vaccine Delivery |
Ramvikas, M.; Arumugam, M.; Chakrabarti, S.R.; Jaganathan, K.S. |
2017 |
2017-12-31 |
PMC |
N |
PMC7151830 |
|
10.1016/b978-0-323-39981-4.00015-4 |
y0tbvs3t |
0.600022 |
Montefiori_2007, Lee_S_2015, Mooney_2013, Tripp_2014 |
Kraan_2014, Corthésy_2018, Bivas-Benita_2005, Wilson_2020 |
108 |
Meunier_2016 |
DNA vaccination of poultry: The current status in 2015 |
Meunier, Marine; Chemaly, Marianne; Dory, Daniel |
2016 |
2016-01-04 |
PMC |
N |
PMC7115526 |
26620840.0 |
10.1016/j.vaccine.2015.11.043 |
asyebua7 |
0.600013 |
Mooney_2013, Tripp_2014, Montefiori_2007 |
Wium_2019, Bande_2015, Dhama_2008, Ploquin_2013 |
109 |
Dhama_2008 |
DNA vaccines and their applications in veterinary practice: current perspectives |
Dhama, K.; Mahendran, Mahesh; Gupta, P. K.; Rai, A. |
2008 |
2008-04-19 |
PMC |
N |
PMC7089108 |
18425596.0 |
10.1007/s11259-008-9040-3 |
0o3mryu1 |
0.598743 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Liu_L_2017, Ingolotti_2010, Tarahomjoo_2011, Wium_2019 |
110 |
Frantz_2018 |
Measles-derived vaccines to prevent emerging viral diseases |
Frantz, Phanramphoei N.; Teeravechyan, Samaporn; Tangy, Frédéric |
2018 |
2018-11-30 |
PMC |
N |
PMC7110469 |
29410084.0 |
10.1016/j.micinf.2018.01.005 |
uk5khcoz |
0.598448 |
Mooney_2013 |
Escriou_2014, Buttigieg_2014, Akahata_2010 |
111 |
Marques_Neto_2017 |
Role of Metallic Nanoparticles in Vaccinology: Implications for Infectious Disease Vaccine Development |
Marques Neto, Lázaro Moreira; Kipnis, André; Junqueira-Kipnis, Ana Paula |
2017 |
2017-03-08 |
COMM-USE |
N |
PMC5340775 |
28337198.0 |
10.3389/fimmu.2017.00239 |
b8sbvy0g |
0.595791 |
Montefiori_2007 |
Cordeiro_2015, Pati_2018 |
112 |
Saxena_2013 |
Pre-existing immunity against vaccine vectors – friend or foe? |
Saxena, Manvendra; Van, Thi Thu Hao; Baird, Fiona J.; Coloe, Peter J.; Smooker, Peter M. |
2013 |
2013-01-23 |
COMM-USE |
N |
PMC3542731 |
23175507.0 |
10.1099/mic.0.049601-0 |
v812zn3r |
0.592668 |
Montefiori_2007, Tripp_2014 |
Tarahomjoo_2011, Singh_2016, Meseda_2016 |
113 |
Crisci_2012 |
Virus-like particles: The new frontier of vaccines for animal viral infections |
Crisci, Elisa; Bárcena, Juan; Montoya, María |
2012 |
2012-08-15 |
PMC |
N |
PMC7112581 |
22705417.0 |
10.1016/j.vetimm.2012.04.026 |
e8l9w41u |
0.592294 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Mühlebach_2016, Akahata_2010, Ploquin_2013, Crisci_2013 |
114 |
Premanand_2018 |
Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development |
Premanand, Balraj; Zhong Wee, Poh; Prabakaran, Mookkan |
2018 |
2018-05-31 |
COMM-USE |
N |
PMC6024371 |
29857561.0 |
10.3390/v10060298 |
45tre8rn |
0.590973 |
Montefiori_2007, Bangari_2006 |
Ploquin_2013, Chen_2007 |
115 |
Okeke_2017 |
Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps? |
Okeke, Malachy I.; Okoli, Arinze S.; Diaz, Diana; Offor, Collins; Oludotun, Taiwo G.; Tryland, Morten; Bøhn, Thomas; Moens, Ugo |
2017 |
2017-10-29 |
COMM-USE |
N |
PMC5707525 |
29109380.0 |
10.3390/v9110318 |
175igdfk |
0.587373 |
Tripp_2014 |
Volz_2017, Ploquin_2013, Falzarano_2011, Meseda_2016 |
116 |
Wiersma_2015 |
Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head |
Wiersma, Lidewij C. M.; Rimmelzwaan, Guus F.; de Vries, Rory D. |
2015 |
2015-03-26 |
COMM-USE |
N |
PMC4494343 |
26343187.0 |
10.3390/vaccines3020239 |
kea2xw1g |
0.582266 |
Mooney_2013, Montefiori_2007 |
Mooney_2013, Elliott_2017 |
117 |
Bhatia_2015 |
Chapter 9 Edible Vaccines |
Bhatia, Saurabh; Dahiya, Randhir |
2015 |
2015-12-31 |
PMC |
N |
PMC7149355 |
|
10.1016/b978-0-12-802221-4.00009-1 |
rtac6hh2 |
0.577667 |
|
Saxena_2013, Criscuolo_2019 |
118 |
Zhang_2014 |
Current advancements and potential strategies in the development of MERS-CoV vaccines |
Zhang, Naru; Jiang, Shibo; Du, Lanying |
2014 |
2014-04-26 |
None |
Y |
PMC4241375 |
24766432.0 |
10.1586/14760584.2014.912134 |
strhszpd |
0.576646 |
Mooney_2013, Tripp_2014 |
|
119 |
Yurina_2018 |
Live Bacterial Vectors—A Promising DNA Vaccine Delivery System |
Yurina, Valentina |
2018 |
2018-03-23 |
COMM-USE |
N |
PMC6024733 |
29570602.0 |
10.3390/medsci6020027 |
lyp24gh5 |
0.575874 |
Tripp_2014, Montefiori_2007, Kopecky-Bromberg_2009, Mooney_2013 |
Detmer_2006, Tarahomjoo_2011, Zakhartchouk_2005, Ingolotti_2010 |
120 |
Li_L_2015 |
Molecular mechanisms for enhanced DNA vaccine immunogenicity |
Li, Lei; Petrovsky, Nikolai |
2015 |
2015-12-28 |
PMC |
N |
PMC4955855 |
26707950.0 |
10.1586/14760584.2016.1124762 |
f30dw3cn |
0.574639 |
Montefiori_2007, Tripp_2014 |
Liu_L_2017, Ingolotti_2010, Saade_2012 |
121 |
Liu_J_2016 |
Virus like particle-based vaccines against emerging infectious disease viruses |
Liu, Jinliang; Dai, Shiyu; Wang, Manli; Hu, Zhihong; Wang, Hualin; Deng, Fei |
2016 |
2016-07-11 |
PMC |
N |
PMC7090901 |
27405928.0 |
10.1007/s12250-016-3756-y |
vt9pbw85 |
0.573543 |
|
Akahata_2010, Mühlebach_2016, Pati_2018 |
122 |
Wang_2015 |
Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies |
Wang, Shujing; Liu, Huiqin; Zhang, Xinyi; Qian, Feng |
2015 |
2015-05-06 |
COMM-USE |
N |
PMC4491048 |
25944045.0 |
10.1007/s13238-015-0164-2 |
sgy2wh8m |
0.572882 |
Mooney_2013, Tripp_2014, Montefiori_2007 |
Criscuolo_2019, Corthésy_2018, Kraan_2014, Liu_H_2013 |
123 |
Suschak_2017 |
Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity |
Suschak, John J.; Williams, James A.; Schmaljohn, Connie S. |
2017 |
2017-06-12 |
NONCOMM |
N |
PMC5718814 |
28604157.0 |
10.1080/21645515.2017.1330236 |
b0izt9hq |
0.566892 |
Montefiori_2007, Li_L_2015 |
Liu_L_2017, Li_L_2015, Ingolotti_2010, Criscuolo_2019 |
124 |
Hajissa_2019 |
Epitope-based vaccine as a universal vaccination strategy against Toxoplasma gondii infection: A mini-review |
Hajissa, Khalid; Zakaria, Robaiza; Suppian, Rapeah; Mohamed, Zeehaida |
2019 |
2019-03-24 |
NONCOMM |
N |
PMC6702889 |
31453188.0 |
10.5455/javar.2019.f329 |
d4rq1du1 |
0.562782 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Jin_J_2018, Keshwara_2019, Meng_2012 |
125 |
McArthur_2011 |
Japanese Encephalitis Vaccines |
McArthur, Monica A.; Holbrook, Michael R. |
2011 |
2011-01-01 |
PMC |
N |
PMC3486421 |
23125946.0 |
10.4172/2157-2526.s1-002 |
tjwkouya |
0.557995 |
Mooney_2013, Tripp_2014 |
Buttigieg_2014, Keshwara_2019, Akahata_2010, Cui_J_2016 |
126 |
Plummer_2010 |
Viral nanoparticles and virus‐like particles: platforms for contemporary vaccine design |
Plummer, Emily M.; Manchester, Marianne |
2010 |
2010-09-24 |
PMC |
N |
PMC7169818 |
20872839.0 |
10.1002/wnan.119 |
wegpeews |
0.555823 |
Montefiori_2007, Mooney_2013, Tripp_2014, Morrison_2010, Liu_J_2016 |
|
127 |
Nuismer_2019 |
Evolution and containment of transmissible recombinant vector vaccines |
Nuismer, Scott L.; Basinski, Andrew; Bull, James J. |
2019 |
2019-06-12 |
COMM-USE |
N |
PMC6708430 |
31462917.0 |
10.1111/eva.12806 |
zs8urh6c |
0.554941 |
Tripp_2014, Montefiori_2007, Welsh_2007, de_Vries_2016 |
Wium_2019, Ploquin_2013, Cruz_2010, Meseda_2016 |
128 |
Kraan_2014 |
Buccal and sublingual vaccine delivery |
Kraan, Heleen; Vrieling, Hilde; Czerkinsky, Cecil; Jiskoot, Wim; Kersten, Gideon; Amorij, Jean-Pierre |
2014 |
2014-09-28 |
PMC |
N |
PMC7114675 |
24911355.0 |
10.1016/j.jconrel.2014.05.060 |
vq72zw0n |
0.553241 |
Montefiori_2007, Lee_S_2015, Curtiss_2015 |
Bivas-Benita_2005, Wilson_2020, Rowe_2019, Hansen_2012 |
129 |
Sakala_2019 |
Neonatal vaccine effectiveness and the role of adjuvants |
Sakala, Isaac G.; Eichinger, Katherine Marie; Petrovsky, Nikolai |
2019 |
2019-07-25 |
PMC |
N |
PMC6678067 |
31293189.0 |
10.1080/1744666x.2019.1642748 |
g9ev443o |
0.545746 |
Montefiori_2007, Mooney_2013, Wiersma_2015, Tripp_2014, Lee_S_2015 |
Honda-Okubo_2015, Jiang_2014, Criscuolo_2019 |
130 |
Cano-Garrido_2015 |
Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes |
Cano-Garrido, Olivia; Seras-Franzoso, Joaquin; Garcia-Fruitós, Elena |
2015 |
2015-09-16 |
COMM-USE |
N |
PMC4573465 |
26377321.0 |
10.1186/s12934-015-0313-6 |
d2l6joyl |
0.543718 |
|
Bermúdez-Humarán_2011, Tarahomjoo_2011, Bermúdez-Humarán_2009, Wells_2008 |
131 |
Saxena_2013 |
Edible Vaccines |
Saxena, Jyoti; Rawat, Shweta |
2013 |
2013-10-22 |
PMC |
N |
PMC7120417 |
|
10.1007/978-81-322-1554-7_12 |
zfh20im0 |
0.542373 |
Mooney_2013 |
Korban_2002, Criscuolo_2019 |
132 |
Tiwari_2009 |
Plants as bioreactors for the production of vaccine antigens |
Tiwari, Siddharth; Verma, Praveen C.; Singh, Pradhyumna K.; Tuli, Rakesh |
2009 |
2009-08-31 |
PMC |
N |
PMC7126855 |
19356740.0 |
10.1016/j.biotechadv.2009.03.006 |
dpwzgake |
0.541904 |
Montefiori_2007 |
Korban_2002, Lamphear_2002 |
133 |
Bande_2015 |
Progress and Challenges toward the Development of Vaccines against Avian Infectious Bronchitis |
Bande, Faruku; Arshad, Siti Suri; Hair Bejo, Mohd; Moeini, Hassan; Omar, Abdul Rahman |
2015 |
2015-04-14 |
COMM-USE |
N |
PMC4411447 |
25954763.0 |
10.1155/2015/424860 |
4hyp1956 |
0.540997 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Falzarano_2011, Ploquin_2013, Nazmi_2017 |
134 |
Britton_2012 |
Modification of the avian coronavirus infectious bronchitis virus for vaccine development |
Britton, Paul; Armesto, Maria; Cavanagh, David; Keep, Sarah |
2012 |
2012-03-01 |
None |
N |
PMC3357331 |
22179147.0 |
10.4161/bbug.18983 |
l56gdz3w |
0.538806 |
Mooney_2013, Tripp_2014 |
Bande_2015 |
135 |
Fuenmayor_2017 |
Production of virus-like particles for vaccines |
Fuenmayor, J.; Gòdia, F.; Cervera, L. |
2017 |
2017-10-25 |
PMC |
N |
PMC7102714 |
28778817.0 |
10.1016/j.nbt.2017.07.010 |
s8qh1wwl |
0.538806 |
Montefiori_2007 |
Kushnir_2012, Syomin_2019, Rosales-Mendoza_2019, Xu_P_2015 |
136 |
Heuking_2011 |
Pulmonary Delivery of Plasmid DNA for Disease Prevention and Therapy |
Heuking, Simon; Borchard, Gerrit |
2011 |
2011-05-25 |
PMC |
N |
PMC7122476 |
|
10.1007/978-1-4419-9745-6_16 |
hrsz15vv |
0.536768 |
Li_L_2015 |
Ingolotti_2010, Bivas-Benita_2005 |
137 |
Beeler_2013 |
Influenza and respiratory syncytial virus (RSV) vaccines for infants: Safety, immunogenicity, and efficacy |
Beeler, Judy A.; Eichelberger, Maryna C. |
2013 |
2013-02-28 |
PMC |
N |
PMC7127028 |
23247146.0 |
10.1016/j.micpath.2012.11.013 |
cotgutwd |
0.533975 |
Mooney_2013, Montefiori_2007 |
Sawada_2011 |
138 |
Rynda-Apple_2014 |
Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung |
Rynda-Apple, Agnieszka; Patterson, Dustin P; Douglas, Trevor |
2014 |
2014-08-01 |
PMC |
N |
PMC4415509 |
25325241.0 |
10.2217/nnm.14.107 |
j5hisbfu |
0.530010 |
Montefiori_2007, Tripp_2014, Mooney_2013 |
Cordeiro_2015, Tarahomjoo_2011 |
139 |
Wells_2008 |
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria |
Wells, Jerry M.; Mercenier, Annick |
2008 |
2008-01-01 |
PMC |
N |
PMC7096801 |
18345021.0 |
10.1038/nrmicro1840 |
5wyay3vh |
0.529160 |
Montefiori_2007, Welsh_2007 |
Bermúdez-Humarán_2009, Tarahomjoo_2011, Bermúdez-Humarán_2011 |
140 |
Gilbert_2017 |
Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology |
Gilbert, Sarah C.; Warimwe, George M. |
2017 |
2017-08-16 |
None |
N |
PMC5571606 |
28576573.0 |
10.1016/j.vaccine.2017.04.085 |
zfuphzeu |
0.527933 |
Mooney_2013 |
Falzarano_2011, Warimwe_2013, Akahata_2010 |
141 |
Gary_2020 |
DNA vaccines: prime time is now |
Gary, Ebony N; Weiner, David B |
2020 |
2020-08-31 |
PMC |
N |
|
|
10.1016/j.coi.2020.01.006 |
lsb64qh4 |
0.527655 |
Li_L_2015, Montefiori_2007 |
Liu_L_2017, Garu_2016, Dhama_2008, Ingolotti_2010 |
142 |
Mason_2011 |
Plant-Derived Antigens as Mucosal Vaccines |
Mason, H. S.; Herbst-Kralovetz, M. M. |
2011 |
2011-08-03 |
PMC |
N |
PMC7122597 |
21811930.0 |
10.1007/82_2011_158 |
zkuj22oc |
0.527458 |
Montefiori_2007, Welsh_2007 |
Tarahomjoo_2011, Lamphear_2002 |
143 |
Wilson_2020 |
Chapter 48 Mucosal Vaccine Development for Veterinary and Aquatic Diseases |
Wilson, Heather L.; Gerdts, Volker; Babiuk, Lorne A. |
2020 |
2020-12-31 |
PMC |
N |
PMC7149622 |
|
10.1016/b978-0-12-811924-2.00048-1 |
r5va3y1n |
0.526565 |
Montefiori_2007 |
Bivas-Benita_2005, Liu_H_2013, Lin_K_2012, Corthésy_2018 |
144 |
Wang_2007 |
Leptospirosis vaccines |
Wang, Zhijun; Jin, Li; Węgrzyn, Alicja |
2007 |
2007-12-11 |
COMM-USE |
N |
PMC2231387 |
18072968.0 |
10.1186/1475-2859-6-39 |
3t4vv50z |
0.525540 |
Mooney_2013, Tripp_2014 |
Buttigieg_2014, Wium_2019, Keshwara_2019, Ploquin_2013 |
145 |
Fynan_2018 |
One Group's Historical Reflections on DNA Vaccine Development |
Fynan, Ellen F.; Lu, Shan; Robinson, Harriet L. |
2018 |
2018-09-01 |
COMM-USE |
N |
PMC6152846 |
30129778.0 |
10.1089/hum.2018.066 |
4z286b5j |
0.524847 |
|
Ingolotti_2010, Li_L_2015 |
146 |
Bishop_1988 |
The release into the environment of genetically engineered viruses, vaccines and viral pesticides |
Bishop, David H.L. |
1988 |
1988-04-30 |
PMC |
N |
|
|
10.1016/0167-7799(88)90006-6 |
lke4y02f |
0.523662 |
Bishop_1988 |
|
147 |
Ludwig_2007 |
Virus-like particles—universal molecular toolboxes |
Ludwig, Christine; Wagner, Ralf |
2007 |
2007-12-31 |
PMC |
N |
PMC7126091 |
18083549.0 |
10.1016/j.copbio.2007.10.013 |
2ljbsia2 |
0.522719 |
Montefiori_2007, Mooney_2013 |
Donaldson_2014, Rosales-Mendoza_2019, Holla_2017, Grgacic_2006 |
148 |
Hodgins_2015 |
Chapter 68 Mucosal Veterinary Vaccines Comparative Vaccinology |
Hodgins, Douglas C.; Chattha, Kuldeep; Vlasova, Anastasia; Parreño, Viviana; Corbeil, Lynette B.; Renukaradhya, Gourapura J.; Saif, Linda J. |
2015 |
2015-12-31 |
PMC |
N |
PMC7149859 |
|
10.1016/b978-0-12-415847-4.00068-9 |
mn8r972x |
0.520049 |
Mooney_2013, Montefiori_2007 |
Wilson_2020, Bande_2015, Gerber_1990 |
149 |
Dolzhikova_2017 |
Virus-Vectored Ebola Vaccines |
Dolzhikova, I.V.; Tokarskaya, E.A.; Dzharullaeva, A. S.; Tukhvatulin, A. I.; Shcheblyakov, D. V.; Voronina, O.L.; Syromyatnikova, S. I.; Borisevich, S. V.; Pantyukhov, V. B.; Babira, V. F.; Kolobukhina, L. V.; Naroditsky, B. S.; Logunov, D. Y.; Gintsburg, A. L. |
2017 |
2017-01-01 |
COMM-USE |
N |
PMC5662269 |
29104771.0 |
|
fu02qqsh |
0.517010 |
Mooney_2013 |
Buttigieg_2014, Akahata_2010, Keshwara_2019, Ploquin_2013 |
150 |
Ewer_2017 |
Chimpanzee adenoviral vectors as vaccines for outbreak pathogens |
Ewer, Katie; Sebastian, Sarah; Spencer, Alexandra J.; Gilbert, Sarah; Hill, Adrian V. S.; Lambe, Teresa |
2017 |
2017-10-30 |
COMM-USE |
N |
PMC5718829 |
29083948.0 |
10.1080/21645515.2017.1383575 |
opi8aa5i |
0.515643 |
Mooney_2013 |
Ploquin_2013, Warimwe_2013, Akahata_2010 |
151 |
Liang_2016 |
A CRISPR/Cas9 and Cre/Lox system-based express vaccine development strategy against re-emerging Pseudorabies virus |
Liang, Xun; Sun, Leqiang; Yu, Teng; Pan, Yongfei; Wang, Dongdong; Hu, Xueying; Fu, Zhenfang; He, Qigai; Cao, Gang |
2016 |
2016-01-18 |
COMM-USE |
N |
PMC4726036 |
26777545.0 |
10.1038/srep19176 |
b9dk07tk |
0.514479 |
Mooney_2013, Tripp_2014 |
Mühlebach_2016, Liu_Z_2014 |
152 |
Olszewska_2006 |
VACCINATIONS | Viral |
Olszewska, W.; Openshaw, P.J.M.; Helson, R. |
2006 |
2006-12-31 |
PMC |
N |
PMC7150349 |
|
10.1016/b0-12-370879-6/00418-x |
593n7614 |
0.513477 |
Mooney_2013, Tripp_2014 |
Elliott_2017, Akahata_2010, Pati_2018 |
153 |
Bivas-Benita_2005 |
Pulmonary DNA vaccination: Concepts, possibilities and perspectives |
Bivas-Benita, Maytal; Ottenhoff, Tom H.M.; Junginger, Hans E.; Borchard, Gerrit |
2005 |
2005-09-20 |
PMC |
N |
PMC7114572 |
16054263.0 |
10.1016/j.jconrel.2005.05.028 |
1n0o6w67 |
0.512209 |
Montefiori_2007, Lee_S_2015, Tripp_2014 |
Wilson_2020, Liu_H_2013, Lin_K_2012, Corthésy_2018 |
154 |
Guan_2013 |
Recent advances and safety issues of transgenic plant-derived vaccines |
Guan, Zheng-jun; Guo, Bin; Huo, Yan-lin; Guan, Zheng-ping; Dai, Jia-kun; Wei, Ya-hui |
2013 |
2013-03-01 |
PMC |
N |
PMC7080054 |
23447052.0 |
10.1007/s00253-012-4566-2 |
wd12nhq5 |
0.511838 |
Montefiori_2007 |
Korban_2002, Gómez_1998 |
155 |
Xia_Y_2015 |
Chitosan-based mucosal adjuvants: Sunrise on the ocean |
Xia, Yufei; Fan, Qingze; Hao, Dongxia; Wu, Jie; Ma, Guanghui; Su, Zhiguo |
2015 |
2015-11-04 |
PMC |
N |
|
26271831.0 |
10.1016/j.vaccine.2015.07.101 |
4qfe8kok |
0.508225 |
Montefiori_2007, Lee_S_2015 |
Cordeiro_2015, Kraan_2014, Corthésy_2018, Sarkar_2013 |
156 |
Fathi_2019 |
Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens |
Fathi, Anahita; Dahlke, Christine; Addo, Marylyn M. |
2019 |
2019-09-05 |
NONCOMM |
N |
PMC6816421 |
31368826.0 |
10.1080/21645515.2019.1649532 |
4cia91cq |
0.505957 |
Mooney_2013 |
Keshwara_2019, Rodriguez_2019, Akahata_2010, Falzarano_2011 |
157 |
Stephenson_2004 |
Confronting the avian influenza threat: vaccine development for a potential pandemic |
Stephenson, Iain; Nicholson, Karl G; Wood, John M; Zambon, Maria C; Katz, Jacqueline M |
2004 |
2004-08-31 |
PMC |
N |
PMC7106438 |
15288823.0 |
10.1016/s1473-3099(04)01105-3 |
zaguyxm5 |
0.500475 |
Mooney_2013 |
Rao_S_2008 |
158 |
Li_S_2007 |
Viral vectors for malaria vaccine development |
Li, Shengqiang; Locke, Emily; Bruder, Joseph; Clarke, David; Doolan, Denise L.; Havenga, Menzo J.E.; Hill, Adrian V.S.; Liljestrom, Peter; Monath, Thomas P.; Naim, Hussein Y.; Ockenhouse, Christian; Tang, De-chu C.; Van Kampen, Kent R.; Viret, Jean-Francois; Zavala, Fidel; Dubovsky, Filip |
2007 |
2007-03-30 |
PMC |
N |
PMC7131149 |
16914237.0 |
10.1016/j.vaccine.2006.07.035 |
8dkj6ps3 |
0.500432 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Mok_H_2012, Mühlebach_2016, Volz_2017 |
159 |
Vemula_2010 |
Production of adenovirus vectors and their use as a delivery system for influenza vaccines |
Vemula, Sai V.; Mittal, Suresh K. |
2010 |
2010-09-08 |
PMC |
N |
PMC2951029 |
20822477.0 |
10.1517/14712598.2010.519332 |
yjcsgg48 |
0.496529 |
Mooney_2013 |
Ploquin_2013, Meseda_2016 |
160 |
Ogonczyk_Makowska_2020 |
Engineering of Live Chimeric Vaccines against Human Metapneumovirus |
Ogonczyk Makowska, Daniela; Hamelin, Marie-Ève; Boivin, Guy |
2020 |
2020-02-19 |
COMM-USE |
N |
PMC7168645 |
32093057.0 |
10.3390/pathogens9020135 |
i8l396il |
0.494572 |
Mooney_2013 |
|
161 |
Choi_2017 |
Newcastle disease virus vectored vaccines as bivalent or antigen delivery vaccines |
Choi, Kang-Seuk |
2017 |
2017-07-26 |
NONCOMM |
N |
PMC5540967 |
28775971.0 |
10.7774/cevr.2017.6.2.72 |
vk59ghjm |
0.490236 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Ploquin_2013, Keshwara_2019, Cruz_2010, Falzarano_2011 |
162 |
LeCureux_2018 |
Lactobacillus Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens |
LeCureux, Jonathan S.; Dean, Gregg A. |
2018 |
2018-05-16 |
COMM-USE |
N |
PMC5956152 |
29769376.0 |
10.1128/msphere.00061-18 |
sllrzyq9 |
0.489814 |
Montefiori_2007 |
Tarahomjoo_2011, Gu_Q_2009, Stoeker_2011, Lin_K_2012 |
163 |
Shim_2013 |
Sublingual Delivery of Vaccines for the Induction of Mucosal Immunity |
Shim, Byoung-Shik; Choi, Youngjoo; Cheon, In Su; Song, Man Ki |
2013 |
2013-06-30 |
NONCOMM |
N |
PMC3718922 |
23885221.0 |
10.4110/in.2013.13.3.81 |
f6q6q3io |
0.489589 |
Montefiori_2007, Curtiss_2015, Mooney_2013 |
Kraan_2014, Wilson_2020, Rowe_2019, Bivas-Benita_2005 |
164 |
Sato_2011 |
Recombinant vaccines against the mononegaviruses—What we have learned from animal disease controls |
Sato, Hiroki; Yoneda, Misako; Honda, Tomoyuki; Kai, Chieko |
2011 |
2011-12-31 |
PMC |
N |
PMC7114506 |
21982973.0 |
10.1016/j.virusres.2011.09.038 |
xvke7sze |
0.485211 |
Tripp_2014 |
Ploquin_2013, Mühlebach_2016, Akahata_2010 |
165 |
Chen_2010 |
Vaccination Strategies to Promote Mucosal Antibody Responses |
Chen, Kang; Cerutti, Andrea |
2010 |
2010-10-29 |
None |
N |
PMC3045856 |
21029959.0 |
10.1016/j.immuni.2010.09.013 |
jxv1ntp8 |
0.482310 |
Montefiori_2007 |
Bivas-Benita_2005, Wilson_2020, Liu_H_2013, Corthésy_2018 |
166 |
Vaine_2009 |
Progress on the induction of neutralizing antibodies against HIV-1 |
Vaine, Michael; Lu, Shan; Wang, Shixia |
2009 |
2009-06-01 |
PMC |
N |
PMC3764985 |
19627166.0 |
10.2165/00063030-200923030-00001 |
qip0l9ss |
0.479879 |
Montefiori_2007, Tripp_2014 |
Zhang_2006 |
167 |
Ertl_2016 |
21 Adenoviral Vector Vaccines Antigen Transgene |
Ertl, Hildegund C.J. |
2016 |
2016-12-31 |
PMC |
N |
PMC7150117 |
|
10.1016/b978-0-12-800276-6.00021-8 |
odeksech |
0.477992 |
Montefiori_2007, Tripp_2014, Bangari_2006 |
Tatsis_2004, Bangari_2006, Mittal_2016, Folegatti_2019 |
168 |
Du_L_2015 |
Middle East respiratory syndrome: current status and future prospects for vaccine development |
Du, Lanying; Jiang, Shibo |
2015 |
2015-09-28 |
None |
N |
PMC4636333 |
26414077.0 |
10.1517/14712598.2015.1092518 |
b44qnmbm |
0.476467 |
Mooney_2013 |
|
169 |
Zaman_2012 |
Strategies for intranasal delivery of vaccines |
Zaman, Mehfuz; Chandrudu, Saranya; Toth, Istvan |
2012 |
2012-07-12 |
COMM-USE |
N |
PMC3539070 |
23316448.0 |
10.1007/s13346-012-0085-z |
kb2wrxio |
0.474030 |
Montefiori_2007, Curtiss_2015 |
Kraan_2014, Bivas-Benita_2005, Corthésy_2018 |
170 |
Lindblad_2017 |
Chapter 18 Mineral Adjuvants ∗ ∗ The present chapter is an updated version of the chapter “Mineral Adjuvants,” published in Immunopotentiators in Modern Vaccines, p. 217–233. Ed. Virgil Schijns & Derek O'Hagan, Elsevier Science Publishers (2005). |
Lindblad, E.B.; Duroux, L. |
2017 |
2017-12-31 |
PMC |
N |
PMC7149584 |
|
10.1016/b978-0-12-804019-5.00018-9 |
w4pbq2lb |
0.472723 |
Montefiori_2007 |
Li_W_2013, Zhang_2016, Sarkar_2013 |
171 |
Walmsley_2003 |
Plant cell factories and mucosal vaccines |
Walmsley, Amanda M; Arntzen, Charles J |
2003 |
2003-04-30 |
PMC |
N |
PMC7135315 |
12732315.0 |
10.1016/s0958-1669(03)00026-0 |
grml98oa |
0.472465 |
Montefiori_2007, Welsh_2007, Tripp_2014 |
Korban_2002, Mason_2015, Streatfield_2001 |
172 |
Zhan_2014 |
Advancing a multivalent ‘Pan-anthelmintic’ vaccine against soil-transmitted nematode infections |
Zhan, Bin; Beaumier, Coreen M; Briggs, Neima; Jones, Kathryn M; Keegan, Brian P; Bottazzi, Maria Elena; Hotez, Peter J |
2014 |
2014-01-06 |
NONCOMM |
N |
PMC3934375 |
24392641.0 |
10.1586/14760584.2014.872035 |
qyflkmi9 |
0.469682 |
Montefiori_2007 |
González-Hernández_2016 |
173 |
Thacker_2009 |
Strategies to overcome host immunity to adenovirus vectors in vaccine development |
Thacker, Erin E; Timares, Laura; Matthews, Qiana L |
2009 |
2009-06-01 |
PMC |
N |
PMC3700409 |
19485756.0 |
10.1586/erv.09.29 |
7a6q4d3h |
0.468205 |
Montefiori_2007, Mooney_2013 |
Borovjagin_2014, Tatsis_2004, Bangari_2006 |
174 |
Zhang_2010 |
Enterovirus 71 vaccine: close but still far |
Zhang, Dingmei; Lu, Jiayuan; Lu, Jiahai |
2010 |
2010-09-30 |
PMC |
N |
PMC7110504 |
20400350.0 |
10.1016/j.ijid.2009.12.002 |
byqhzyzi |
0.467799 |
Mooney_2013, Tripp_2014 |
Keshwara_2019, Chen_2012 |
175 |
Khamis_2018 |
Porcine Epidemic Diarrhea Virus |
Khamis, Zayn; Menassa, Rima |
2018 |
2018-05-03 |
PMC |
N |
PMC7120993 |
|
10.1007/978-3-319-90137-4_12 |
app590vw |
0.463525 |
Mooney_2013 |
|
176 |
Tan_M_2014 |
Subviral particle as vaccine and vaccine platform |
Tan, Ming; Jiang, Xi |
2014 |
2014-06-30 |
None |
N |
PMC4072748 |
24662314.0 |
10.1016/j.coviro.2014.02.009 |
36jv8r34 |
0.461564 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Jin_J_2018, Lauer_2016, Tan_M_2017 |
177 |
Liu_H_2015 |
Receptor Binding Domain Based HIV Vaccines |
Liu, Huan; Bi, Wenwen; Wang, Qian; Lu, Lu; Jiang, Shibo |
2015 |
2015-01-15 |
COMM-USE |
N |
PMC4312573 |
25667925.0 |
10.1155/2015/594109 |
v1t564l2 |
0.457557 |
Montefiori_2007, Tripp_2014, Mooney_2013 |
|
178 |
Zhang_2016 |
Adenoviral vector-based strategies against infectious disease and cancer |
Zhang, Chao; Zhou, Dongming |
2016 |
2016-04-22 |
NONCOMM |
N |
PMC4994731 |
27105067.0 |
10.1080/21645515.2016.1165908 |
a3nzj6yh |
0.452956 |
Montefiori_2007, Tatsis_2004, Mooney_2013 |
Tatsis_2004, Borovjagin_2014, Ertl_2016 |
179 |
Xu_Y_2014 |
Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives |
Xu, Yingying; Yuen, Pak-Wai; Lam, Jenny Ka-Wing |
2014 |
2014-07-10 |
COMM-USE |
N |
PMC4190526 |
25014738.0 |
10.3390/pharmaceutics6030378 |
0bma2749 |
0.447201 |
Mooney_2013, Tripp_2014, Montefiori_2007 |
Bivas-Benita_2005, Zakhartchouk_2005, Jiao_2011 |
180 |
Vicente_2011 |
Large-scale production and purification of VLP-based vaccines |
Vicente, Tiago; Roldão, António; Peixoto, Cristina; Carrondo, Manuel J.T.; Alves, Paula M. |
2011 |
2011-07-31 |
PMC |
N |
PMC7094596 |
21784230.0 |
10.1016/j.jip.2011.05.004 |
ghsil7jz |
0.447115 |
Mooney_2013, Tripp_2014 |
Syomin_2019, Kushnir_2012, Loureiro_2012, Mühlebach_2016 |
181 |
Garg_2017 |
Advances Towards Painless Vaccination and Newer Modes of Vaccine Delivery |
Garg, Neha; Aggarwal, Anju |
2017 |
2017-06-16 |
PMC |
N |
PMC7090876 |
28620730.0 |
10.1007/s12098-017-2377-2 |
0s81kuwt |
0.446596 |
Mooney_2013 |
Criscuolo_2019, Kraan_2014, Meseda_2016, Kim_Y_2011 |
182 |
Fagone_2010 |
Electroporation-Mediated DNA Vaccination |
Fagone, Paolo; Shedlock, Devon J.; Kemmerer, Stephen; Rabussay, Dietmar; Weiner, David B. |
2010 |
2010-12-15 |
PMC |
N |
PMC7122510 |
|
10.1007/978-1-4419-8363-3_18 |
fbotc479 |
0.446405 |
Montefiori_2007, Li_L_2015, Welsh_2007 |
Liu_L_2017, Garu_2016, Bråve_2010 |
183 |
Schlake_2018 |
mRNA as novel technology for passive immunotherapy |
Schlake, Thomas; Thess, Andreas; Thran, Moritz; Jordan, Ingo |
2018 |
2018-10-17 |
COMM-USE |
N |
PMC6339677 |
30334070.0 |
10.1007/s00018-018-2935-4 |
ke0az7nf |
0.445892 |
|
Hao_H_2008 |
184 |
Rosales-Mendoza_2019 |
Virus-Like Particles-Based Mucosal Nanovaccines |
Rosales-Mendoza, Sergio; González-Ortega, Omar |
2019 |
2019-11-08 |
PMC |
N |
PMC7120988 |
|
10.1007/978-3-030-31668-6_10 |
bfi48hcn |
0.445255 |
Mooney_2013, Montefiori_2007, Tripp_2014 |
Chen_2013, Akahata_2010 |
185 |
Nakayama_2016 |
Recombinant measles AIK-C vaccine strain expressing heterologous virus antigens |
Nakayama, Tetsuo; Sawada, Akihito; Yamaji, Yoshiaki; Ito, Takashi |
2016 |
2016-01-04 |
PMC |
N |
PMC7115616 |
26562316.0 |
10.1016/j.vaccine.2015.10.127 |
4vkag60z |
0.444005 |
Mooney_2013 |
Sawada_2011, Mühlebach_2016, Mok_H_2012 |
186 |
Draper_2013 |
Utilizing poxviral vectored vaccines for antibody induction—Progress and prospects |
Draper, Simon J.; Cottingham, Matthew G.; Gilbert, Sarah C. |
2013 |
2013-09-06 |
PMC |
N |
PMC7131268 |
23746455.0 |
10.1016/j.vaccine.2013.05.091 |
a6m8elu9 |
0.441380 |
Montefiori_2007 |
Ploquin_2013, Akahata_2010 |
187 |
Kushnir_2012 |
Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development |
Kushnir, Natasha; Streatfield, Stephen J.; Yusibov, Vidadi |
2012 |
2012-12-17 |
PMC |
N |
PMC7115575 |
23142589.0 |
10.1016/j.vaccine.2012.10.083 |
nxn63xbw |
0.440551 |
Montefiori_2007 |
Mühlebach_2016, Loureiro_2012, Tarahomjoo_2011 |
188 |
Robert-Guroff_2007 |
Replicating and non-replicating viral vectors for vaccine development |
Robert-Guroff, Marjorie |
2007 |
2007-12-31 |
None |
N |
PMC2245896 |
18063357.0 |
10.1016/j.copbio.2007.10.010 |
c4s4tnwr |
0.438451 |
Montefiori_2007 |
Lauer_2016, Cervantes-Barragan_2010, Mühlebach_2016, Busch_2020 |
189 |
Moody_2014 |
Modulation of HIV-1 immunity by adjuvants |
Moody, M. Anthony |
2014 |
2014-04-10 |
NONCOMM |
N |
PMC3984023 |
24670321.0 |
10.1097/coh.0000000000000052 |
1nm1tbig |
0.437200 |
Montefiori_2007 |
Vaine_2009, Zhang_2006 |
190 |
Karch_2017 |
The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria |
Karch, Christopher P.; Doll, Tais A. P. F.; Paulillo, Sara M.; Nebie, Issa; Lanar, David E.; Corradin, Giampietro; Burkhard, Peter |
2017 |
2017-09-06 |
COMM-USE |
N |
PMC5588597 |
28877692.0 |
10.1186/s12951-017-0295-0 |
z8db3qi6 |
0.430702 |
Welsh_2007, Montefiori_2007 |
Chen_2007 |
191 |
Permyakova_2015 |
State of research in the field of the creation of plant vaccines for veterinary use |
Permyakova, N. V.; Uvarova, E. A.; Deineko, E. V. |
2015 |
2015-01-04 |
PMC |
N |
PMC7089518 |
|
10.1134/s1021443715010100 |
d9szap94 |
0.430094 |
|
Korban_2002, Mason_2015 |
192 |
Roy_P_2009 |
Virus-Like Particles as a Vaccine Delivery System: Myths and Facts |
Roy, Polly; Noad, Rob |
2009 |
2009-12-30 |
PMC |
N |
PMC7124136 |
20047040.0 |
10.1007/978-1-4419-1132-2_11 |
xwbcfh6p |
0.429629 |
Mooney_2013, Tripp_2014 |
Mühlebach_2016, Akahata_2010, Smith_2006 |
193 |
Ramsauer_2016 |
Chikungunya Virus Vaccines: Viral Vector–Based Approaches |
Ramsauer, Katrin; Tangy, Frédéric |
2016 |
2016-12-15 |
PMC |
N |
PMC7107338 |
27920181.0 |
10.1093/infdis/jiw369 |
sp87qdkr |
0.429553 |
Mooney_2013, Tripp_2014 |
Akahata_2010, Ploquin_2013, Keshwara_2019, Weger-Lucarelli_2014 |
194 |
Petroski_2017 |
Chapter 10 Advax Adjuvant A Potent and Safe Immunopotentiator Composed of Delta Inulin |
Petroski, N. |
2017 |
2017-12-31 |
PMC |
N |
PMC7150192 |
|
10.1016/b978-0-12-804019-5.00010-4 |
qxzc8gfb |
0.429488 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Zhang_2016, Li_W_2013, Petrovsky_2015 |
195 |
Wang_2016 |
Recent advances in the production of recombinant subunit vaccines in Pichia pastoris |
Wang, Man; Jiang, Shuai; Wang, Yefu |
2016 |
2016-04-08 |
None |
N |
PMC4927204 |
27246656.0 |
10.1080/21655979.2016.1191707 |
l49eqs2h |
0.426003 |
|
Korban_2002, Lamphear_2002 |
196 |
Broadbent_2015 |
Chapter 59 Respiratory Virus Vaccines |
Broadbent, Andrew J.; Boonnak, Kobporn; Subbarao, Kanta |
2015 |
2015-12-31 |
PMC |
N |
PMC7149605 |
|
10.1016/b978-0-12-415847-4.00059-8 |
dcui85lw |
0.423273 |
Montefiori_2007, Mooney_2013 |
Lee_Y_2018, Eroglu_2016 |
197 |
Dimitrov_2017 |
Newcastle disease vaccines—A solved problem or a continuous challenge? |
Dimitrov, Kiril M.; Afonso, Claudio L.; Yu, Qingzhong; Miller, Patti J. |
2017 |
2017-07-31 |
PMC |
N |
PMC7131810 |
28024856.0 |
10.1016/j.vetmic.2016.12.019 |
w6wxsg4p |
0.421346 |
Mooney_2013, Tripp_2014 |
Bande_2015, Buttigieg_2014, Ploquin_2013 |
198 |
Gursel_2020 |
Is Global BCG Vaccination Coverage Relevant To The Progression Of SARS-CoV-2 Pandemic? |
Gursel, Mayda; Gursel, Ihsan |
2020 |
2020-04-06 |
PMC |
Y |
|
|
10.1016/j.mehy.2020.109707 |
uei9zw6q |
0.418795 |
Tripp_2014, Montefiori_2007, Mooney_2013, Wiersma_2015, Lambe_2012 |
Escriou_2014, Gai_W_2011 |
199 |
DuBourdieu_2019 |
Colostrum Antibodies, Egg Antibodies and Monoclonal Antibodies Providing Passive Immunity for Animals |
DuBourdieu, Dan |
2019 |
2019-03-11 |
PMC |
N |
PMC7123268 |
|
10.1007/978-3-030-04624-8_18 |
jdu4h00e |
0.416972 |
Montefiori_2007 |
|
200 |
Dormitzer_2008 |
Structure-based antigen design: a strategy for next generation vaccines |
Dormitzer, Philip R.; Ulmer, Jeffrey B.; Rappuoli, Rino |
2008 |
2008-12-31 |
PMC |
N |
PMC7114313 |
18977045.0 |
10.1016/j.tibtech.2008.08.002 |
bp9ubajv |
0.416925 |
Montefiori_2007 |
Sesterhenn_2018, Cordeiro_2015, Jin_J_2018 |
201 |
Zhou_2007 |
Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly |
Zhou, Xianfeng; Liu, Bin; Yu, Xianghui; Zha, Xiao; Zhang, Xizhen; Wang, Xueyun; Chen, Yu; Chen, Yan; Chen, Yue; Shan, Yaming; Jin, Yinghua; Wu, Yongge; Liu, Junqiu; Kong, Wei; Shen, Jiacong |
2007 |
2007-11-30 |
PMC |
N |
PMC7124441 |
17686512.0 |
10.1016/j.biomaterials.2007.07.002 |
d03byeee |
0.414182 |
Montefiori_2007, Tripp_2014 |
Chen_2013, Cordeiro_2015, Garu_2016 |
202 |
Holla_2017 |
Chapter Sixteen Toward Mucosal DNA Delivery: Structural Modularity in Vaccine Platform Design |
Holla, P.; Baikoghli, M.A.; Soonsawad, P.; Cheng, R.H. |
2017 |
2017-12-31 |
PMC |
N |
PMC7152392 |
|
10.1016/b978-0-323-39981-4.00016-6 |
l9m6flpy |
0.414182 |
|
Lee_T_2017, Tarahomjoo_2011 |
203 |
Rhee_2020 |
Chapter 19 Current and New Approaches for Mucosal Vaccine Delivery |
Rhee, Joon Haeng |
2020 |
2020-12-31 |
PMC |
N |
PMC7149853 |
|
10.1016/b978-0-12-811924-2.00019-5 |
7rmzaau4 |
0.413614 |
Montefiori_2007, Mooney_2013, Tripp_2014, Lee_S_2015, Wiersma_2015 |
Kraan_2014, Wilson_2020, Corthésy_2018, Bivas-Benita_2005 |
204 |
Bermúdez-Humarán_2011 |
Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines |
Bermúdez-Humarán, Luis G; Kharrat, Pascale; Chatel, Jean-Marc; Langella, Philippe |
2011 |
2011-08-30 |
COMM-USE |
N |
PMC3231930 |
21995317.0 |
10.1186/1475-2859-10-s1-s4 |
ojosqwwc |
0.410282 |
|
Tarahomjoo_2011, Bermúdez-Humarán_2009, Gu_Q_2009, Stoeker_2011 |
205 |
Starodubova_2010 |
Regulation of Immunogen Processing: Signal Sequences and Their Application for the New Generation of DNA-Vaccines |
Starodubova, E.S.; Isaguliants, M.G.; Karpov, V.L. |
2010 |
2010-04-23 |
COMM-USE |
N |
PMC3347541 |
22649628.0 |
|
dmzn79tq |
0.408738 |
Montefiori_2007 |
Ingolotti_2010, Kim_S_2012, Dhama_2008 |
206 |
Petrovsky_2015 |
Comparative safety of vaccine adjuvants: a summary of current evidence and future needs |
Petrovsky, Nikolai |
2015 |
2015-10-08 |
None |
N |
PMC4615573 |
26446142.0 |
10.1007/s40264-015-0350-4 |
f2u1di1q |
0.406833 |
Montefiori_2007, Lee_S_2015, Mooney_2013 |
Jiang_2014, Lee_S_2015, Liu_L_2017, Dietrich_2014 |
207 |
Petrovsky_2016 |
Chapter 3 SARS coronavirus infections of the lower respiratory tract and their prevention |
Petrovsky, N. |
2016 |
2016-12-31 |
PMC |
N |
PMC7149758 |
|
10.1016/b978-0-12-804543-5.00003-8 |
fb832hlp |
0.405631 |
Mooney_2013 |
Escriou_2014 |
208 |
Yong_2019 |
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus |
Yong, Chean Yeah; Ong, Hui Kian; Yeap, Swee Keong; Ho, Kok Lian; Tan, Wen Siang |
2019 |
2019-08-02 |
COMM-USE |
N |
PMC6688523 |
31428074.0 |
10.3389/fmicb.2019.01781 |
bb5dnbbt |
0.397534 |
Mooney_2013 |
Escriou_2014, Chi_H_2017 |
209 |
Roper_2014 |
SARS vaccines: where are we? |
Roper, Rachel L; Rehm, Kristina E |
2014 |
2014-01-09 |
PMC |
N |
PMC7105754 |
19538115.0 |
10.1586/erv.09.43 |
y4eyse0y |
0.396679 |
Mooney_2013, Montefiori_2007, Tripp_2014 |
Gai_W_2011, Falzarano_2011, Escriou_2014, Okada_2007 |
210 |
van_Oers_2006 |
Vaccines for Viral and Parasitic Diseases Produced with Baculovirus Vectors |
van Oers, Monique M. |
2006 |
2006-12-31 |
PMC |
N |
PMC7112334 |
16997013.0 |
10.1016/s0065-3527(06)68006-8 |
e0m0h926 |
0.396377 |
Montefiori_2007 |
Mühlebach_2016, Gómez_1998, Zakhartchouk_2005 |
211 |
Zolla-Pazner_2004 |
Identifying epitopes of HIV-1 that induce protective antibodies |
Zolla-Pazner, Susan |
2004 |
2004-01-01 |
PMC |
N |
PMC7097025 |
15039757.0 |
10.1038/nri1307 |
zetj7mxz |
0.392449 |
Montefiori_2007 |
Jin_J_2018, Vaine_2009 |
212 |
Kopecky-Bromberg_2009 |
Recombinant Vectors as Influenza Vaccines |
Kopecky-Bromberg, Sarah A.; Palese, Peter |
2009 |
2009-06-15 |
PMC |
N |
PMC7115000 |
19768410.0 |
10.1007/978-3-540-92165-3_13 |
pnl1acrj |
0.388056 |
Mooney_2013, Tripp_2014 |
de_Vries_2016, Mooney_2013, Elliott_2017 |
213 |
Jacobson_2009 |
Genetic basis for variation of vaccine response: our studies with rubella vaccine |
Jacobson, Robert M.; Ovsyannikova, Inna G.; Poland, Gregory A. |
2009 |
2009-12-01 |
PMC |
N |
PMC2957833 |
20976024.0 |
10.1016/j.paed.2009.08.019 |
5z6m8s6r |
0.385008 |
Montefiori_2007, Mooney_2013, Wiersma_2015, Tripp_2014 |
|
214 |
Bull_2019 |
Recombinant vector vaccines and within-host evolution |
James Bull; Scott L. Nuismer; Rustom Antia |
2019 |
2019-02-08 |
BioRxiv |
N |
|
|
10.1101/545087 |
3vssgben |
0.384450 |
Bull_2019 |
Bull_2019, Mühlebach_2016, Nuismer_2019, Zuniga_2007 |
215 |
Hangalapura_2012 |
CD40-targeted adenoviral cancer vaccines: the long and winding road to the clinic |
Hangalapura, Basav N.; Timares, Laura; Oosterhoff, Dinja; Scheper, Rik J.; Curiel, David T.; de Gruijl, Tanja D. |
2012 |
2012-06-01 |
PMC |
N |
PMC3433169 |
22228547.0 |
10.1002/jgm.1648 |
7mi07qm9 |
0.383762 |
Montefiori_2007 |
Garu_2016, Cervantes-Barragan_2010 |
216 |
Enjuanes_2010 |
Recombinant Live Vaccines to Protect Against the Severe Acute Respiratory Syndrome Coronavirus |
Enjuanes, Luis; Nieto-Torres, Jose L.; Jimenez-Guardeño, Jose M.; DeDiego, Marta L. |
2010 |
2010-07-07 |
PMC |
N |
PMC7123558 |
|
10.1007/978-3-0346-0277-8_4 |
1ksz6nmx |
0.383626 |
|
Escriou_2014, Enjuanes_2008, Gai_W_2011, Haagmans_2009 |
217 |
Mohamed_2012 |
Protective Immunity to Listeria Monocytogenes Infection Mediated by Recombinant Listeria innocua Harboring the VGC Locus |
Mohamed, Walid; Sethi, Shneh; Tchatalbachev, Svetlin; Darji, Ayub; Chakraborty, Trinad |
2012 |
2012-04-19 |
COMM-USE |
N |
PMC3334901 |
22536395.0 |
10.1371/journal.pone.0035503 |
wbj0w365 |
0.382119 |
Montefiori_2007, Wang_2011 |
Bahey-El-Din_2008, Wium_2019 |
218 |
Grgacic_2006 |
Virus-like particles: Passport to immune recognition |
Grgacic, Elizabeth V.L.; Anderson, David A. |
2006 |
2006-09-30 |
PMC |
N |
PMC7128828 |
16997714.0 |
10.1016/j.ymeth.2006.07.018 |
fhs5wlw4 |
0.382007 |
Montefiori_2007 |
Syomin_2019, Donaldson_2014, Ludwig_2007, Roy_P_2009 |
219 |
UNKNOWN_2020 |
Poster Presentations |
None |
2020 |
2020-01-10 |
PMC |
N |
PMC7163607 |
31342511.0 |
10.1111/dmcn.14411 |
sxd4t2tz |
0.375392 |
|
|
220 |
Falzarano_2011 |
Progress in filovirus vaccine development: evaluating the potential for clinical use |
Falzarano, Darryl; Geisbert, Thomas W; Feldmann, Heinz |
2011 |
2011-01-01 |
PMC |
N |
PMC3398800 |
21162622.0 |
10.1586/erv.10.152 |
64o52qhp |
0.375014 |
Mooney_2013 |
Buttigieg_2014, Keshwara_2019, Ploquin_2013, Akahata_2010 |
221 |
Cruz-Reséndiz_2020 |
A self-aggregating peptide: implications for the development of thermostable vaccine candidates |
Cruz-Reséndiz, Adolfo; Zepeda-Cervantes, Jesús; Sampieri, Alicia; Bastián-Eugenio, Carlos; Acero, Gonzalo; Sánchez-Betancourt, J. Iván; Gevorkian, Goar; Vaca, Luis |
2020 |
2020-01-21 |
COMM-USE |
N |
PMC6971912 |
31959159.0 |
10.1186/s12896-019-0592-9 |
fpygaht5 |
0.375012 |
Montefiori_2007, Welsh_2007 |
Sarkar_2013, Cordeiro_2015 |
222 |
Cavanagh_1985 |
Viral and bacterial vectors of immunogenes |
Cavanagh, David |
1985 |
1985-03-31 |
PMC |
N |
|
4002835.0 |
10.1016/0264-410x(85)90011-8 |
507necw8 |
0.372811 |
Mooney_2013, Tripp_2014 |
Mühlebach_2016, Mok_H_2012, Ploquin_2013 |
223 |
Zhou_2010 |
NS-based Live Attenuated H1N1 Pandemic Vaccines Protect Mice and Ferrets |
Zhou, Bin; Li, Yan; Belser, Jessica A.; Pearce, Melissa B.; Schmolke, Mirco; Subba, Anju X.; Shi, Zhengli; Zaki, Sherif R.; Blau, Dianna M.; García-Sastre, Adolfo; Tumpey, Terrence M.; Wentworth, David E. |
2010 |
2010-11-01 |
PMC |
N |
PMC2991506 |
20934458.0 |
10.1016/j.vaccine.2010.08.106 |
wvot6rfc |
0.371952 |
Mooney_2013 |
Akahata_2010, Escriou_2014 |
224 |
Muthumani_2016 |
Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus |
Muthumani, Karuppiah; Block, Peter; Flingai, Seleeke; Muruganantham, Nagarajan; Chaaithanya, Itta Krishna; Tingey, Colleen; Wise, Megan; Reuschel, Emma L.; Chung, Christopher; Muthumani, Abirami; Sarangan, Gopalsamy; Srikanth, Padma; Khan, Amir S.; Vijayachari, Paluru; Sardesai, Niranjan Y.; Kim, J. Joseph; Ugen, Kenneth E.; Weiner, David B. |
2016 |
2016-03-21 |
PMC |
N |
PMC4936642 |
27001960.0 |
10.1093/infdis/jiw111 |
6fhltomk |
0.369711 |
Montefiori_2007, Mooney_2013, Tripp_2014 |
Elliott_2017, Zakhartchouk_2005, Akahata_2010 |
225 |
Lamphear_2002 |
Delivery of subunit vaccines in maize seed |
Lamphear, Barry J; Streatfield, Stephen J; Jilka, Joseph M; Brooks, Christopher A; Barker, Donna K; Turner, Debra D; Delaney, Donna E; Garcia, Martin; Wiggins, Barry; Woodard, Susan L; Hood, Elizabeth E; Tizard, Ian R; Lawhorn, Bruce; Howard, John A |
2002 |
2002-12-13 |
PMC |
N |
PMC7127645 |
12480322.0 |
10.1016/s0168-3659(02)00282-1 |
rshpyyfj |
0.369556 |
Montefiori_2007 |
Gómez_1998, Lamphear_2004 |
226 |
Deville_2012 |
Load reduction in live PRRS vaccines using oil and polymer adjuvants |
Deville, Sebastien; Arous, Juliette Ben; Ionkoff, Ghislaine; Kukushkin, François Bertranda Sergey; Baybikov, Taufik; Borisov, Vladimir; Dupuis, Laurent |
2012 |
2012-12-31 |
PMC |
N |
PMC7128483 |
|
10.1016/j.provac.2012.04.018 |
mpoqcfja |
0.369550 |
Mooney_2013, Tripp_2014, Montefiori_2007 |
Jiang_2014, Rajan_2014, Roberts_2010, Deville_2012 |
227 |
Tsen_2014 |
Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment |
Tsen, Shaw-Wei David; Donthi, Nisha; La, Victor; Hsieh, Wen-Han; Li, Yen-Der; Knoff, Jayne; Chen, Alexander; Wu, Tzyy-Choou; Hung, Chien-Fu; Achilefu, Samuel; Tsen, Kong-Thon |
2014 |
2014-11-25 |
PMC |
N |
PMC4242973 |
25423046.0 |
10.1117/1.jbo.20.5.051008 |
s8g465c5 |
0.367844 |
Mooney_2013, Montefiori_2007, Tripp_2014 |
Zakhartchouk_2005, Elliott_2017 |
228 |
Mühlebach_2016 |
Development of Recombinant Measles Virus-Based Vaccines |
Mühlebach, Michael D.; Hutzler, Stefan |
2016 |
2016-11-26 |
PMC |
N |
PMC7121886 |
28374248.0 |
10.1007/978-1-4939-6869-5_9 |
cmbg0ty8 |
0.365522 |
|
Zuniga_2007, Mok_H_2012 |
229 |
Corthésy_2018 |
Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection |
Corthésy, Blaise; Bioley, Gilles |
2018 |
2018-03-07 |
COMM-USE |
N |
PMC5845866 |
29563912.0 |
10.3389/fimmu.2018.00431 |
bdi8v79t |
0.364719 |
Montefiori_2007 |
Wilson_2020, Bivas-Benita_2005, Liu_H_2013, Cordeiro_2015 |
230 |
Bråve_2010 |
Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation |
Bråve, Andreas; Gudmundsdotter, Lindvi; Sandström, Eric; Haller, B. Kristian; Hallengärd, David; Maltais, Anna-Karin; King, Alan D.; Stout, Richard R.; Blomberg, Pontus; Höglund, Urban; Hejdeman, Bo; Biberfeld, Gunnel; Wahren, Britta |
2010 |
2010-11-29 |
PMC |
N |
PMC7126493 |
20951666.0 |
10.1016/j.vaccine.2010.08.108 |
bhdly6oh |
0.361606 |
Li_L_2015, Tripp_2014, Welsh_2007 |
Meseda_2016, Criscuolo_2019, Hu_H_2009 |
231 |
Mooney_2013 |
Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses |
Mooney, Alaina J; Tompkins, S Mark |
2013 |
2013-01-01 |
PMC |
N |
PMC3579652 |
23440999.0 |
10.2217/fvl.12.122 |
fq78593b |
0.360696 |
|
de_Vries_2016, Stephenson_2004 |
232 |
Hansen_2012 |
Nanoparticles for transcutaneous vaccination |
Hansen, Steffi; Lehr, Claus‐Michael |
2012 |
2012-02-20 |
PMC |
N |
PMC3815776 |
21854553.0 |
10.1111/j.1751-7915.2011.00284.x |
0lsobcnl |
0.360678 |
Montefiori_2007, Welsh_2007, Salvador_2011 |
Ishii_2008, Kraan_2014, Corthésy_2018, Cordeiro_2015 |
233 |
Menachery_2018 |
Combination attenuation offers strategy for live-attenuated coronavirus vaccines |
Vineet D. Menachery; Lisa E. Gralinski; Hugh D. Mitchell; Kenneth H. Dinnon; Sarah R. Leist; Boyd L. Yount; Eileen T. McAnarney; Rachel L. Graham; Katrina M. Waters; Ralph S. Baric |
2018 |
2018-04-28 |
BioRxiv |
N |
|
|
10.1101/309591 |
3t75dbb7 |
0.360500 |
Tripp_2014, Mooney_2013 |
Escriou_2014, Chen_2012 |
234 |
Bangari_2006 |
Development of nonhuman adenoviruses as vaccine vectors |
Bangari, Dinesh S.; Mittal, Suresh K. |
2006 |
2006-02-13 |
None |
N |
PMC1462960 |
16297508.0 |
10.1016/j.vaccine.2005.08.101 |
v5n1gupw |
0.358354 |
Tatsis_2004 |
Tatsis_2004, Mittal_2016 |
235 |
Jain_2020 |
Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopes |
Neha Jain; Uma Shankar; Prativa Majee; Amit Kumar |
2020 |
2020-04-01 |
BioRxiv |
Y |
|
|
10.1101/2020.03.26.009209 |
lmstdmyb |
0.353451 |
Montefiori_2007, Tripp_2014, Welsh_2007, Mooney_2013 |
Escriou_2014 |
236 |
Marcotte_2015 |
Chapter 71 Passive Immunization Toward Magic Bullets |
Marcotte, Harold; Hammarström, Lennart |
2015 |
2015-12-31 |
PMC |
N |
PMC7150278 |
|
10.1016/b978-0-12-415847-4.00071-9 |
9a2yruq0 |
0.352602 |
Montefiori_2007 |
Bivas-Benita_2005, Jin_J_2018, Liu_H_2013 |
237 |
Wang_2013 |
DNA Immunization |
Wang, Shixia; Lu, Shan |
2013 |
2013-11-05 |
PMC |
N |
PMC3920301 |
24510291.0 |
10.1002/9780471729259.mc1803s31 |
g8yzmtkj |
0.352071 |
Liu_S_2016, Li_L_2015 |
Ingolotti_2010, Liu_S_2016, Hao_H_2008 |
238 |
Curtiss_2015 |
Chapter 64 Antigen Delivery System II Development of Live Attenuated Bacterial Vectors |
Curtiss, Roy |
2015 |
2015-12-31 |
PMC |
N |
PMC7148735 |
|
10.1016/b978-0-12-415847-4.00064-1 |
xa6km2ev |
0.351419 |
Montefiori_2007 |
Tarahomjoo_2011, Lee_T_2017, Corthésy_2018 |
239 |
de_Vries_2016 |
Viral vector-based influenza vaccines |
de Vries, Rory D.; Rimmelzwaan, Guus F. |
2016 |
2016-07-25 |
COMM-USE |
N |
PMC5137548 |
27455345.0 |
10.1080/21645515.2016.1210729 |
tocqabgu |
0.350465 |
Mooney_2013 |
Mooney_2013, Tripp_2014, Mühlebach_2016 |
240 |
Kim_H_2016 |
Recent vaccine technology in industrial animals |
Kim, Hyunil; Lee, Yoo-kyoung; Kang, Sang Chul; Han, Beom Ku; Choi, Ki Myung |
2016 |
2016-01-27 |
NONCOMM |
N |
PMC4742593 |
26866019.0 |
10.7774/cevr.2016.5.1.12 |
gckqphhp |
0.350465 |
Schwartz_2007, Mooney_2013 |
Mühlebach_2016, Liu_X_2019 |
241 |
Weir_2018 |
The Safety of an Adjuvanted Autologous Cancer Vaccine Platform in Canine Cancer Patients |
Weir, Chris; Oksa, Annika; Millar, Jennifer; Alexander, Miles; Kynoch, Nicola; Walton-Weitz, Zoe; Mackenzie-Wood, Peter; Tam, Felicia; Richards, Hope; Naylor, Richard; Cheng, Katrina; Bennett, Peter; Petrovsky, Nikolai; Allavena, Rachel |
2018 |
2018-10-12 |
COMM-USE |
N |
PMC6313922 |
30322015.0 |
10.3390/vetsci5040087 |
visvv73i |
0.349050 |
Deville_2012, Montefiori_2007, Welsh_2007, Lee_S_2015 |
Hutzler_2017 |
242 |
Chen_2013 |
Virus-like Particle Vaccines for Norovirus Gastroenteritis |
Chen, Qiang |
2013 |
2013-06-10 |
PMC |
N |
PMC7122369 |
|
10.1007/978-3-7091-1419-3_8 |
uzqnv7m8 |
0.348507 |
Mooney_2013 |
Akahata_2010 |
243 |
Wilk_2018 |
CD4 T(RM) Cells Following Infection and Immunization: Implications for More Effective Vaccine Design |
Wilk, Mieszko M.; Mills, Kingston H. G. |
2018 |
2018-08-10 |
COMM-USE |
N |
PMC6095996 |
30147701.0 |
10.3389/fimmu.2018.01860 |
efmkqvza |
0.348203 |
Montefiori_2007 |
Busch_2020 |
244 |
Korban_2002 |
Targeting and expression of antigenic proteins in transgenic plants for production of edible oral vaccines |
Korban, Schuyler S. |
2002 |
2002-01-01 |
PMC |
N |
PMC7088994 |
|
10.1079/ivp2002292 |
kac96l0a |
0.343994 |
|
Mason_2015, Gómez_1998 |
245 |
Tan_M_2017 |
Recent advancements in combination subunit vaccine development |
Tan, Ming; Jiang, Xi |
2017 |
2017-01-02 |
PMC |
N |
PMC5287306 |
27649319.0 |
10.1080/21645515.2016.1229719 |
ixfrp8ub |
0.340584 |
|
Mühlebach_2016, Kushnir_2012 |
246 |
Volz_2017 |
Chapter Five Modified Vaccinia Virus Ankara History, Value in Basic Research, and Current Perspectives for Vaccine Development |
Volz, A.; Sutter, G. |
2017 |
2017-12-31 |
PMC |
N |
PMC7112317 |
28057259.0 |
10.1016/bs.aivir.2016.07.001 |
cngz535o |
0.337828 |
Mooney_2013 |
Ploquin_2013, Drexler_2004, Falzarano_2011 |
247 |
Agnihothram_2018 |
Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform |
Agnihothram, Sudhakar; Menachery, Vineet D.; Yount, Boyd L.; Lindesmith, Lisa C.; Scobey, Trevor; Whitmore, Alan; Schäfer, Alexandra; Heise, Mark T.; Baric, Ralph S. |
2018 |
2018-05-14 |
COMM-USE |
N |
PMC5952155 |
29540599.0 |
10.1128/jvi.00027-18 |
isypu1ga |
0.335854 |
Tripp_2014, Mooney_2013 |
Akahata_2010, Warimwe_2013, Falzarano_2011 |
248 |
Kenner_2006 |
LC16m8: An attenuated smallpox vaccine |
Kenner, Julie; Cameron, Fiona; Empig, Cyril; Jobes, David V.; Gurwith, Marc |
2006 |
2006-11-17 |
PMC |
N |
PMC7115618 |
17052815.0 |
10.1016/j.vaccine.2006.03.087 |
lfn9ggg3 |
0.335393 |
Mooney_2013, Tripp_2014 |
Falzarano_2011 |
249 |
Dory_2015 |
Targeted Collection of Plasmid DNA in Large and Growing Animal Muscles 6 Weeks after DNA Vaccination with and without Electroporation |
Dory, Daniel; Le Moigne, Vincent; Cariolet, Roland; Béven, Véronique; Keranflec'h, André; Jestin, André |
2015 |
2015-08-25 |
COMM-USE |
N |
PMC4561992 |
26380318.0 |
10.1155/2015/326825 |
yq190ig9 |
0.334749 |
|
Fagone_2010, Ingolotti_2010, Mühlebach_2016, Hao_H_2008 |
250 |
Chen_2016 |
Synthetic virus-like particles prepared via protein corona formation enable effective vaccination in an avian model of coronavirus infection |
Chen, Hui-Wen; Huang, Chen-Yu; Lin, Shu-Yi; Fang, Zih-Syun; Hsu, Chen-Hsuan; Lin, Jung-Chen; Chen, Yuan-I; Yao, Bing-Yu; Hu, Che-Ming J. |
2016 |
2016-11-30 |
PMC |
N |
PMC7112462 |
27552321.0 |
10.1016/j.biomaterials.2016.08.018 |
61wibso4 |
0.334346 |
Montefiori_2007 |
Lee_T_2017, Escriou_2014 |
251 |
Ploquin_2013 |
Protection Against Henipavirus Infection by Use of Recombinant Adeno-Associated Virus–Vector Vaccines |
Ploquin, Aurélie; Szécsi, Judit; Mathieu, Cyrille; Guillaume, Vanessa; Barateau, Véronique; Ong, Kien Chai; Wong, Kum Thong; Cosset, François-Loïc; Horvat, Branka; Salvetti, Anna |
2013 |
2013-02-01 |
PMC |
N |
PMC7107322 |
23175762.0 |
10.1093/infdis/jis699 |
u1xbkaq0 |
0.331557 |
Mooney_2013, Schwartz_2007 |
Akahata_2010, Keshwara_2019, Buttigieg_2014 |
252 |
Fedosyuk_2019 |
Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components |
Fedosyuk, Sofiya; Merritt, Thomas; Peralta-Alvarez, Marco Polo; Morris, Susan J; Lam, Ada; Laroudie, Nicolas; Kangokar, Anilkumar; Wright, Daniel; Warimwe, George M; Angell-Manning, Phillip; Ritchie, Adam J; Gilbert, Sarah C; Xenopoulos, Alex; Boumlic, Anissa; Douglas, Alexander D |
2019 |
2019-11-08 |
None |
N |
PMC6949866 |
31047679.0 |
10.1016/j.vaccine.2019.04.056 |
u8y47qmd |
0.330967 |
Kopecky-Bromberg_2009, Tripp_2014 |
Bangari_2006, Tatsis_2004, Hammond_2005 |
253 |
Okba_2017 |
Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches |
Okba, Nisreen MA; Raj, V Stalin; Haagmans, Bart L |
2017 |
2017-04-30 |
PMC |
N |
PMC7102752 |
28412285.0 |
10.1016/j.coviro.2017.03.007 |
w1l8h8g8 |
0.330931 |
Mooney_2013 |
Adney_2019 |
254 |
Mittal_2016 |
19 Xenogenic Adenoviral Vectors |
Mittal, Suresh K.; Ahi, Yadvinder S.; Vemula, Sai V. |
2016 |
2016-12-31 |
PMC |
N |
PMC7149625 |
|
10.1016/b978-0-12-800276-6.00019-x |
mxtry60e |
0.328085 |
Bangari_2006 |
Bangari_2006, Ploquin_2013 |
255 |
Kim_S_2016 |
Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines |
Kim, Shin-Hee; Samal, Siba K. |
2016 |
2016-07-04 |
COMM-USE |
N |
PMC4974518 |
27384578.0 |
10.3390/v8070183 |
axkdf5vu |
0.327194 |
Schwartz_2007 |
Keshwara_2019, Akahata_2010 |
256 |
Hou_Y_2019 |
Emerging Highly Virulent Porcine Epidemic Diarrhea Virus: Molecular Mechanisms of Attenuation and Rational Design of Live Attenuated Vaccines |
Hou, Yixuan; Wang, Qiuhong |
2019 |
2019-11-04 |
COMM-USE |
N |
PMC6862049 |
31689903.0 |
10.3390/ijms20215478 |
2mhhtpcr |
0.326916 |
Mooney_2013, Tripp_2014 |
Yuan_2017, Do_V_2020 |
257 |
Peek_2008 |
Nanotechnology in vaccine delivery |
Peek, Laura J.; Middaugh, C. Russell; Berkland, Cory |
2008 |
2008-05-22 |
PMC |
N |
PMC7103321 |
18325628.0 |
10.1016/j.addr.2007.05.017 |
mqitzpkx |
0.325708 |
Montefiori_2007, Mooney_2013, Tripp_2014, de_Vries_2016 |
Marques_Neto_2017, Cordeiro_2015, Criscuolo_2019 |
258 |
Masavuli_2017 |
Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C |
Masavuli, Makutiro Ghislain; Wijesundara, Danushka K.; Torresi, Joseph; Gowans, Eric J.; Grubor-Bauk, Branka |
2017 |
2017-12-05 |
COMM-USE |
N |
PMC5723323 |
29259601.0 |
10.3389/fmicb.2017.02413 |
auum3tn7 |
0.324113 |
Mooney_2013, Montefiori_2007 |
Akahata_2010 |
259 |
Streatfield_2001 |
Plant-based vaccines: unique advantages |
Streatfield, Stephen J.; Jilka, Joseph M.; Hood, Elizabeth E.; Turner, Debra D.; Bailey, Michele R.; Mayor, Jocelyne M.; Woodard, Susan L.; Beifuss, Katherine K.; Horn, Michael E.; Delaney, Donna E.; Tizard, Ian R.; Howard, John A. |
2001 |
2001-03-21 |
PMC |
N |
PMC7127671 |
11257418.0 |
10.1016/s0264-410x(00)00512-0 |
rcf6rlzo |
0.322904 |
Montefiori_2007 |
Lamphear_2002, Korban_2002, Lamphear_2004, Mason_2015 |
260 |
Altenburg_2014 |
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases |
Altenburg, Arwen F.; Kreijtz, Joost H. C. M.; de Vries, Rory D.; Song, Fei; Fux, Robert; Rimmelzwaan, Guus F.; Sutter, Gerd; Volz, Asisa |
2014 |
2014-07-17 |
COMM-USE |
N |
PMC4113791 |
25036462.0 |
10.3390/v6072735 |
lvf1z9i4 |
0.321531 |
Mooney_2013 |
Akahata_2010, Wang_2019, Sawada_2011, Mok_H_2012 |
261 |
Loureiro_2012 |
Virus Glycoproteins Tagged with the Human Fc Domain as Second Generation Vaccine Candidates |
Loureiro, Silvia; Robinson, Elena; Chen, Hongying; Phapugrangkul, Pongsathon; Colaco, Camilo; Jones, Ian M |
2012 |
2012-03-29 |
PMC |
N |
PMC7122206 |
|
10.1007/978-94-007-4543-8_3 |
kt5awf8i |
0.320953 |
Montefiori_2007 |
Chen_2007 |
262 |
Girard_2008 |
Mucosal immunity and HIV/AIDS vaccines Report of an International Workshop, 28–30 October 2007 |
Girard, Marc P.; Bansal, Geetha P.; Pedroza-Martins, Livia; Dodet, Betty; Mehra, Vijay; Schito, Marco; Mathieson, Bonnie; Delfraissy, Jean-François; Bradac, James |
2008 |
2008-07-29 |
PMC |
N |
PMC7131112 |
18513838.0 |
10.1016/j.vaccine.2008.04.051 |
ku6n3851 |
0.319950 |
Montefiori_2007, Mooney_2013 |
Liu_H_2013, Gerber_1990, Bivas-Benita_2005, Zolla-Pazner_2004 |
263 |
Petrovsky_2015 |
Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety |
Petrovsky, Nikolai; Cooper, Peter D. |
2015 |
2015-11-04 |
None |
N |
PMC4639457 |
26407920.0 |
10.1016/j.vaccine.2015.09.030 |
05dsghbw |
0.319681 |
Montefiori_2007, Mooney_2013, Tripp_2014, Lee_S_2015, de_Vries_2016 |
Petroski_2017, Li_W_2013, Cordeiro_2015 |
264 |
Tripp_2014 |
Virus-Vectored Influenza Virus Vaccines |
Tripp, Ralph A.; Tompkins, S. Mark |
2014 |
2014-08-07 |
COMM-USE |
N |
PMC4147686 |
25105278.0 |
10.3390/v6083055 |
neclg3gb |
0.318710 |
Mooney_2013 |
Zakhartchouk_2005, Elliott_2017, de_Vries_2016, Barefoot_2009 |
265 |
Zhang_2011 |
Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine |
Zhang, XiZhen; Wang, XiaoDan; Zhao, DongHai; Meng, XiangYu; Zhao, XingHong; Yu, XiangHui; Kong, Wei |
2011 |
2011-12-16 |
NONCOMM |
N |
PMC7089044 |
22173311.0 |
10.1007/s11427-011-4244-0 |
xxypq3wd |
0.317868 |
Montefiori_2007 |
Azizi_2006, Zhang_2006, Jiang_2006, Mühlebach_2016 |
266 |
Lambe_2012 |
Novel Viral Vectored Vaccines for the Prevention of Influenza |
Lambe, Teresa |
2012 |
2012-06-19 |
PMC |
N |
PMC3510293 |
22735755.0 |
10.2119/molmed.2012.00147 |
lclxrwcm |
0.316605 |
Mooney_2013 |
Elliott_2017, Tripp_2014, Escriou_2014 |
267 |
Donaldson_2014 |
Virus-Like Particles, a Versatile Subunit Vaccine Platform |
Donaldson, Braeden; Al-Barwani, Farah; Young, Vivienne; Scullion, Sarah; Ward, Vernon; Young, Sarah |
2014 |
2014-08-28 |
PMC |
N |
PMC7121566 |
|
10.1007/978-1-4939-1417-3_9 |
czqzsppq |
0.315288 |
Montefiori_2007 |
Kushnir_2012, Ludwig_2007, Kim_S_2012, Mühlebach_2016 |
268 |
Lamphear_2004 |
A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine |
Lamphear, Barry J.; Jilka, Joseph M.; Kesl, Lyle; Welter, Mark; Howard, John A.; Streatfield, Stephen J. |
2004 |
2004-06-23 |
PMC |
N |
PMC7126512 |
15193404.0 |
10.1016/j.vaccine.2003.11.066 |
0t4uxmj2 |
0.315174 |
Montefiori_2007, Tripp_2014, Mooney_2013, Deville_2012 |
Rajan_2014, Lamphear_2002, Tarahomjoo_2011 |
269 |
Pandey_2018 |
Novel Immunoinformatics Approaches to Design Multi-epitope Subunit Vaccine for Malaria by Investigating Anopheles Salivary Protein |
Pandey, Rajan Kumar; Bhatt, Tarun Kumar; Prajapati, Vijay Kumar |
2018 |
2018-01-18 |
COMM-USE |
N |
PMC5773588 |
29348555.0 |
10.1038/s41598-018-19456-1 |
4evbeijx |
0.313284 |
|
Chen_2007 |
270 |
Bishop_1988 |
The release into the environment of genetically engineered viruses, vaccines and viral pesticides |
Bishop, David H.L. |
1988 |
1988-04-30 |
PMC |
N |
|
|
10.1016/0169-5347(88)90130-9 |
s1zl9nbb |
0.311372 |
Bishop_1988 |
|
271 |
Fausther-Bovendo_2014 |
Pre-existing immunity against Ad vectors: Humoral, cellular, and innate response, what's important? |
Fausther-Bovendo, Hugues; Kobinger, Gary P |
2014 |
2014-11-01 |
NONCOMM |
N |
PMC5443060 |
25483662.0 |
10.4161/hv.29594 |
3894l9qi |
0.304284 |
Montefiori_2007, Singh_2016 |
Croyle_2008, Pandey_2012 |
272 |
Chen_2018 |
Parainfluenza virus 5–vectored vaccines against human and animal infectious diseases |
Chen, Zhenhai |
2018 |
2018-01-05 |
PMC |
N |
PMC7169218 |
29316047.0 |
10.1002/rmv.1965 |
6r8wvn9s |
0.303913 |
Mooney_2013 |
|
273 |
Rajan_2014 |
An Oral Vaccine for TGEV Immunization of Pigs |
Rajan, V. |
2014 |
2014-05-28 |
PMC |
N |
PMC7120389 |
|
10.1007/978-3-662-43836-7_8 |
2ix6c0he |
0.300775 |
Mooney_2013, Tripp_2014, Schwartz_2007 |
Gerber_1990, Hu_M_2007 |
274 |
Sakhatskyy_2008 |
Immunogenicity and Protection Efficacy of Subunit-based Smallpox Vaccines Using Variola Major Antigens |
Sakhatskyy, Pavlo; Wang, Shixia; Zhang, Chuanyou; Chou, Te-Hui; Kishko, Michael; Lu, Shan |
2008 |
2008-02-01 |
PMC |
N |
PMC2254135 |
17950773.0 |
10.1016/j.virol.2007.09.029 |
e11tqf7s |
0.300631 |
Mooney_2013, Montefiori_2007 |
Ploquin_2013, Akahata_2010, Keshwara_2019 |
275 |
Kim_Y_2011 |
Delivery Systems for Intradermal Vaccination |
Kim, Y. C.; Jarrahian, C.; Zehrung, D.; Mitragotri, S.; Prausnitz, M. R. |
2011 |
2011-04-07 |
PMC |
N |
PMC3173582 |
21472533.0 |
10.1007/82_2011_123 |
1gd006zy |
0.300460 |
Mooney_2013, Tripp_2014, Deville_2012 |
Meseda_2016, Criscuolo_2019, Hansen_2012 |